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Aims:  Given the association between Post Traumatic Stress Disorder (PTSD) and 
substance misuse, research efforts have focussed on developing psychosocial 
interventions for these co-morbid conditions.  The purpose of this systematic review was 
to examine the efficacy of these interventions for individuals with co-morbid PTSD and 
substance misuse.  Specifically, this review aimed to identify whether there is evidence 
that the psychosocial interventions which have been used with this population improve 
PTSD, substance misuse, and both PTSD and substance misuse outcomes. 
 
Methods:  This review included any Uncontrolled or Controlled Trials of psychosocial 
interventions for adults with co-occurring PTSD and substance misuse published from 
2005 to 2010.  The search strategy involved electronic databases, hand-searching of 
reference lists and the website of one expert on co-morbid PTSD and substance misuse.  
In total, ten studies were included and the methodological quality of each study was 
assessed using a purpose-designed Quality Assessment Tool.   
 
Results:  The review identified improvements in PTSD outcomes using both trauma 
focussed and non-trauma focussed interventions, specifically Seeking Safety, and 
Contingency Management and Behavioural Therapy.   The evidence suggested that 
psychosocial interventions which have been developed for other psychological problems, 
such as Behavioural Couples Therapy, can improve substance misuse outcomes.  Finally, 
a number of interventions, namely Cognitive Behavioural Therapy and Seeking Safety, 
were shown to improve both PTSD and substance misuse outcomes. 
 
Conclusions:  While this review concluded that a number of psychosocial interventions 
can improve a range of PTSD and substance misuse outcomes, it also highlighted 
variation in the methodological rigour of the studies supporting these interventions.   
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1.  Introduction 
1.1 Overview of Post Traumatic Stress Disorder  
Post Traumatic Stress Disorder (PTSD) is characterised by the intrusive and unwanted re-
experiencing of traumatic events, hyper-arousal, emotional numbing and the avoidance of 
trauma-related stimuli [1].  For individuals to meet diagnostic criteria for PTSD, DSM-VI [2] 
states that a person must have been exposed to a traumatic event that involved actual or 
threatened death, or serious injury to the self or other people, with their responses 
involving intense fear, hopelessness or horror.  While individuals with PTSD frequently 
experience difficulty in intentional recall of the traumatic event, which is often fragmented 
with missing details and is poorly organised in terms of the exact temporal order of events 
[3], involuntarily triggered intrusive memories occur with high frequency and events are re-
experienced in a vivid and distressing way [1].  A range of psychological problems are 
reported to co-occur with PTSD, including depression, anxiety and substance use 
disorders, with estimates of between 75% and 90% of individuals with PTSD also meeting 
diagnostic criteria for other psychological problems [4, 5].   
 
1.2 Co-morbid PTSD and Substance Misuse 
When considering the impact of PTSD on psychological functioning, substance misuse 
has been reported as playing a role in assisting individuals to regain control over 
distressing emotions and intrusive reliving of experiences [6].  This suggests that 
substance misuse serves a short-term protective function for individuals wishing to 
dampen down their heightened arousal and to continue their avoidance of PTSD 
triggering events and memories [7].   
 
Using substances also increases the risk of exposure to traumatic events which could 
lead to the development of PTSD, and it has been suggested that a higher number of 
traumatic events are experienced by those who use substances [8].  For example, a 
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greater risk of assault among substance users compared to non-substance using 
individuals has been identified [9].  Additionally, drug use in previously non-victimised 
women has been related to an increased risk of new assault over and above other socio-
demographic variables such as age, race and education level [10].   
 
Clearly, there is an association between experiencing trauma and using substances, with 
estimates of the prevalence of co-morbid PTSD and substance misuse ranging from 1% 
to 7.8% [11].  As research has indicated that experiencing co-occurring PTSD and 
substance misuse compromises the effectiveness of psychosocial intervention for both 
problems [12] and that these individuals encounter higher rates of hospitalisation, greater 
rates of relapse and higher ongoing, poly-substance use than either PTSD or substance 
misuse alone [13, 14], recent research efforts have focussed on developing specific 
interventions for these co-morbid conditions.  Given the evidence suggesting that 
individuals in clinical populations such as psychosis use substances to self-medicate [15] 
and report expectations that substance use will decrease negative emotions [16], many of 
these interventions aim to reduce negative affect and to increase coping skills.   
 
1.3 Reviews of Psychosocial Interventions for Co-morbid PTSD and Substance 
Misuse 
A recent article [17] reviewed the application of one psychosocial intervention which is 
effective for PTSD, Exposure Therapy [18], to individuals with co-morbid PTSD and 
substance misuse.  The authors report that the available research indicates the 
usefulness of this type of intervention in reducing both PTSD and substance misuse 
symptoms in individuals with co-morbid problems, but they advise that more rigorous 
research is needed.  These authors also state that existing interventions for PTSD should 
be adapted when working with this population, rather than developing new interventions 
for co-occurring PTSD and substance misuse.  Moreover, a summary of the research on a 
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number of time-limited interventions for co-morbid PTSD and substance misuse [19] 
suggested that there is preliminary evidence for these interventions reducing symptoms of 
both conditions.  The authors likewise conclude that more research, with longer follow-up 
periods, is required.   
 
As both of these review articles provide a summary of the research to date and surmise 
that more research with increased methodological rigour is required, it was decided that 
using a systematic approach to reviewing subsequent evidence for psychosocial 
interventions for co-occurring PTSD and substance misuse would be appropriate.  
 
1.4 Aims 
This systematic review aims to examine the efficacy of psychosocial interventions for 
individuals with co-morbid PTSD and substance misuse.  Specifically, this review plans to 
identify whether there is evidence that the psychosocial interventions which have been 
used with this population: 
 
i) Improve PTSD outcomes 
 
ii) Improve substance misuse outcomes 
 
iii) Improve both PTSD and substance misuse outcomes 
 
1.5 Terminology Used in this Review 
It should be noted that a range of terms are used to describe substance misuse.  The 
phrase “substance misuse” is used throughout this review as a descriptor of problematic 
substance use and is considered to capture a range of substance-using behaviours. 
  
 
 
10 
 
When reporting the findings of each of the studies included in this review, however, the 
terms used are those of the study authors, e.g. “substance use disorder.”   
 
1.6 Types of Studies 
This review included any trials of psychosocial interventions for co-occurring PTSD and 
substance misuse published from 2005 to 2010.  This timescale was identified as being 
appropriate, given that the literature reviews published in 2006 [17, 19] clarified the need 
for more research into interventions for this client group.  Only peer-reviewed, published, 
English language studies were included.  Review papers and book chapters which 
represented expert view were excluded, as were unpublished dissertations and 
conference papers. 
 
1.7 Types of Participants 
Participants were adult males and females with a diagnosis of PTSD and co-morbid 
substance misuse, including both alcohol and illicit drug misuse.  Trials where participants 
did not meet diagnostic criteria for PTSD were not included in this review.  Studies which 
did not include PSTD or substance misuse related outcomes, such as clinician views on 
the interventions or dissemination articles which did not report outcomes, were also 
excluded. 
 
1.8 Types of Interventions 
All Uncontrolled or Controlled Trials of psychosocial interventions versus standard care 
(i.e. treatment as usual) or other psychosocial interventions were included. 
 
1.9 Types of Outcome Measures 
The main outcome measures used to assess the efficacy of psychosocial interventions for 
co-morbid PTSD and substance misuse were reported PTSD and substance misuse 
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symptoms.  Many studies also included other psychological and social outcomes; 
however, these were not the main focus of this systematic review.    
 
2.  Methods 
2.1 Overview of the Search Strategy 
The search strategy involved the following sources: 
 
2.1.1 Electronic Databases 
Text Word searching of Ovid MEDLINE, All Evidence-Based Medicine Reviews, British 
Nursing Index, Embase, ERIC, PsychINFO, Social Work Abstracts, and Social Policy and 
Practice, together with Title and Topic searching of the Web of Science database were 
undertaken.  The search terms consisted of: 
 PTSD or post traumatic stress disorder* or trauma* or traumatic life event* 
 co-morbid* or dual-diagnos* or dual diagnos* 
 substance depend* or substance misus* or substance abus* or substance addict* 
or drug depend* or drug misus* or drug abus* or drug addict* or alcohol depend* 
or alcohol misus* or alcohol abus* or alcohol addict* or alcohol* or alcohol 
dependence syndrome or alcohol dependence disorder or substance dependence 
syndrome or substance dependence disorder 
 psychological intervention* or psycholog* intervention* or CBT or cognitive 
behavio?r therap* or cognitive therap* or behavio?r therap* or cognitive adj3 
therap* or behavio?r adj3 therap* or cognitive adj3 therap* or exposure therap* or 
exposure adj3 therap* or seeking safety or seeking adj3 safety 
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2.1.2 Reference Lists 
The reference lists of relevant papers drawn from the electronic databases were hand-
searched in order to test the sensitivity of the search strategy. 
 
2.1.3 Internet Searching 
The website (www.seekingsafety.org) of one expert in the field of co-morbid PTSD and 
substance misuse, Dr. Lisa Najavits (Professor of Psychiatry, Boston University School of 
Medicine; Lecturer, Harvard Medical School; Clinical Psychologist, Veteran’s Association 
Boston; and Clinical Associate, McLean Hospital), was accessed to highlight any 
additional published trials relevant to the review. 
 
3.  Data Collection and Analysis 
3.1 Selection of Trials 
A total of 11 English language articles were initially identified by searching Ovid 
MEDLINE, All Evidence-Based Medicine Reviews, British Nursing Index, Embase, ERIC, 
PsychINFO, Social Work Abstracts, and Social Policy and Practice electronic databases 
using appropriate publication year limits.  The titles and abstracts of these articles were 
reviewed for suitability, and applying the inclusion and exclusion criteria identified two 
suitable articles. 
 
A Web of Science Title Search revealed no suitable articles, whereas a Topic Search 
identified 30 possible articles, which were reduced to six articles after reviewing the 
abstracts and applying the inclusion and exclusion criteria. 
 
Hand-searching reference lists identified a further five possible studies which were 
ultimately excluded from the review, suggesting that the electronic search strategy was 
appropriate for the review topic.  
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Reviewing the website of one expert in the field identified a further two suitable articles 
from a possible nine articles, resulting in a total of ten articles being assessed in this 
review.  Of these ten articles, two utilised the same data.  Figure 1 provides an overview 
of the outcome for the search strategy.  
 
[Insert Figure 1]  
 
The selection of suitable trials was undertaken by one reviewer, and where there was 
ambiguity about the eligibility of a trial for inclusion in the review, this was discussed with 
an independent reviewer using the inclusion and exclusion criteria.  This was in fact only 
necessary for one potential study [20], which was ultimately excluded from the review.  
 
3.2 Data Extraction 
Data were extracted from each eligible trial involving the population characteristics of 
participants, details of the interventions used and outcome measures used to evaluate the 
efficacy of the intervention studies.   
 
3.3 Quality Assessment 
The methodological quality of each of the studies was assessed using a purpose-
designed Quality Assessment Tool.  This tool was devised using both the SIGN 
methodology for critical appraisal of research [21] and the Clinical Trials Assessment 
Measure [22] for Randomised Control Trials (RCTs).  Employing this tool involved rating 
different aspects of each study in seven areas, as below: 
 
Objectives and Study Type  
Aims, questions or hypotheses clearly stated or described; study type (Randomised 
Controlled Trial, Controlled Trial or Uncontrolled Trial). 
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Sampling 
Sample type (geographic cohort, convenience sample or highly selective); baseline 
demographics and clinical characteristics of groups clearly stated; inclusion and exclusion 
criteria specified and used for both groups; sample size adequate (i.e. 27 in each group, 
as defined by the Clinical Trials Assessment Measure) or based on power calculation; 
well-matched control group used or attempts to control for confounding variables; 
diagnostic criteria for PTSD and substance misuse applied, e.g. DSM-IV. 
 
Allocation  
Process of allocation to groups adequately described; allocation carried out independently 
of trial research team. 
 
Assessment of Outcomes 
Assessment carried out independently of therapists; standardised measures of PTSD and 
substance misuse applied (i.e. reliability and validity data specified). 
 
Intervention 
Intervention adequately described or intervention protocol used; adherence to intervention 
protocol used or intervention quality assessed. 
 
Data Analysis 
Data analysis appropriate to study design and type of outcome measure; intention to treat 
analysis used; attrition rates specified; results clearly stated and related to research aim or 
hypotheses; confidence intervals, effect sizes, p-values etc. provided where appropriate. 
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Discussion 
Recommendations for clinical practice and future research identified from results; 
limitations of study clearly identified. 
 
Each aspect of these seven areas was rated on a three-point scale, specifically Adequate, 
Partial and Inadequate (or equivalent descriptors), and allocated a possible score of 2 
(=Adequate), 1 (=Partial) or 0 (=Inadequate), giving a total possible score of 44.  The final 
score for each trial was calculated as a percentage, which was then converted into a 
descriptive quality rating.  These descriptors encompassed Excellent (>75%), Good 
(>60%), Fair (>50%) and Poor (<49%).   
 
A copy of the Quality Assessment Tool used to assess each study in this review is 
provided in Appendix 1.2.  
 
Each of the articles was again reviewed by an independent reviewer in order to assess 
the reliability of the Quality Assessment Tool.  There was complete agreement with this 
reviewer as to the descriptive quality rating given to all ten of the papers. 
 
4.  Results 
4.1 General Findings 
A summary of each of the ten studies is provided in Table 1.1 to clarify the clinical 
heterogeneity of the trials in this review.  Studies were grouped together and presented in 
relation to the types of interventions used.  These were then categorised as studies which 
examined broad classifications of psychosocial interventions (i.e. considered a range of 
interventions together) [23, 24], trials which considered one specific psychosocial 
intervention, Seeking Safety [25, 26, 27, 28, 29], trauma-informed educational 
interventions [30], Behavioural Couples Therapy [31] and Contingency Management and 
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Behaviour Therapy [32].  For categories of studies involving a number of different trials, 
i.e. Seeking Safety interventions, trials are presented in order of publication date.   
 
[Insert Table 1.1] 
 
In general, the majority of the studies [24, 25, 26, 27, 28, 29, 30, 31, 32] described clear 
aims and research hypotheses, and all the above studies related their results to these 
hypotheses, with seven [23, 24, 25, 28, 29, 31, 32] doing this well.  Additionally, limitations 
of the studies were clearly [23, 24, 25, 28, 29, 30, 31, 32] or partially [27] identified in the 
majority of the trials.   
 
4.1.1 Study Type 
Of the ten studies, three [25, 26, 30] were Uncontrolled Trials, a further three [24, 27, 31] 
were Controlled Trials and the remaining four [23, 28, 29, 32] were Randomised 
Controlled Trials (RCTs).  Of these four RCTs, two [28, 29] utilised the same data set. 
 
4.1.2 Sample Characteristics 
Study participants were most frequently recruited from community or outpatient settings 
(eight in total) [23, 25, 26, 27, 28, 29, 31, 32], with one [30] recruiting from a residential 
setting and one [24] recruiting participants from both settings.  Half of the trials [24, 27, 28, 
29, 30] involved women only, with a further two [25, 31] comprising men only or men and 
their non-substance using female partners, and the remaining three [23, 26, 32] involving 
both men and women.  Of note, three of the trials [26, 27, 31] considered veterans and 
seven [23, 24, 25, 28, 29, 30, 32] examined non-veterans, while two [27, 32] focussed on 
homeless populations, compared to eight [23, 24, 25, 26, 28, 29, 30, 31] which did not 
focus on this population.   
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Of the ten studies, two [25, 26] used highly selective samples, such as study volunteers 
who responded to recruitment flyers.  A further five [23, 27, 30, 31, 32] used convenience 
samples, including outpatient clinic attendees and individuals in a residential setting, and 
the remaining three [24, 28, 29] utilised geographical cohort samples.   
 
Sample sizes ranged from as few as five study participants to 450 participants, with seven 
of the studies [23, 24, 27, 28, 29, 30, 32] utilising an adequate sample size (i.e. 27 per 
group).  None, however, reported a power calculation on which sample size was based.   
 
The baseline characteristics and clinical characteristics of participants were reported for 
all studies, with inclusion and exclusion criteria being clearly or partially stated for eight of 
the trials [23, 24, 25, 26, 27, 28, 29, 32].  Additionally, diagnostic criteria for PTSD and 
substance misuse were used at baseline for eight of the studies [23, 24, 25, 28, 29, 30, 
31, 32].   
 
4.1.3 Interventions Used 
Psychosocial Interventions 
Of the ten studies, one [23] examined a range of psychological interventions (Cognitive 
Therapy, Individual Supportive-Expressive Therapy, Psychodynamic and 12-step 
individual and 12-step group counselling) in the context of cocaine-dependent participants 
with substance use disorder, with and without co-occurring PTSD.  A further trial [24] 
included two separate interventions, Seeking Safety and Relapse Prevention, under the 
umbrella of Cognitive Behavioural Therapy (CBT), and compared this to a non-
intervention control group.  Relapse Prevention has been described as a self-control 
programme, involving behavioural skills training, cognitive interventions and lifestyle 
change procedures [33], while the Seeking Safety intervention is outlined overleaf. 
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Seeking Safety  
Seeking Safety [34] is a manualised, trauma-focussed intervention and was used in five of 
the studies.  Of these studies [25, 26, 27, 28, 29], one did not utilise a comparative control 
group [26], one compared Seeking Safety to treatment as usual [27] and two studies [28, 
29] used the same data set to compare Seeking Safety with Women’s Health Education.  
A further Uncontrolled Trial [25] examined Seeking Safety with an additional component, 
Exposure Therapy-Revised, an adapted version of Exposure Therapy for PTSD [18].   
 
Trauma-Focussed Interventions 
A further study [30] looked at the impact of two trauma-focussed interventions, Helping 
Women Recover [35] and Beyond Trauma [36].  The first of these, Helping Women 
Recover, is primarily psycho-educational in nature, while Beyond Trauma aims to assist 
with the expression and containment of emotive responses to trauma. 
 
Behavioural Couples Therapy 
Of the ten studies, one [31] examined Behavioural Couples Therapy for clients with PTSD 
and substance misuse.  This intervention used a Recovery Contract to promote 
abstinence from substance use, and counselling techniques to increase positive activities 
and to improve communication between couples [37].   
 
Contingency Management and Behavioural Treatment 
Finally, one study [32] compared Contingency Management to Contingency Management 
and Behavioural Treatment.  The Contingency Management intervention involved 
abstinence-contingent housing and vocational training, while the additional Behavioural 
Treatment included goal development, review and attainment reinforcement, individual 
counselling and recreational outings.   
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When assessing how well these interventions were described in the study, only one [23] 
did not give adequate or partial information relating to intervention type.  Furthermore, six 
of the studies [23, 24, 26, 28, 31, 32] did not report if intervention adherence or quality 
was assessed.   
 
4.1.4 Domains of Outcomes  
A range of outcomes for the trials was employed in the articles, including intensity and 
frequency of PTSD symptoms, and indices of substance misuse.  Of the ten trials, two 
[26, 32] considered PTSD symptoms without substance misuse, two [23, 31] involved 
substance misuse measures without PTSD symptom changes and the remaining six [24, 
25, 27, 28, 29, 30] considered both PTSD and substance misuse outcomes.   
 
Of the studies, two [28, 29] measured only PTSD or substance misuse symptoms, with 
the remaining eight encompassing a range of interpersonal and intrapersonal outcomes.  
Intrapersonal outcomes included measures of psychological functioning (such as 
depression, anxiety, dissociation and self-esteem), sexual functioning and self-reported 
quality of life, while intrapersonal outcomes comprised of family, relationship and 
interpersonal functioning, alongside perceived social support.  Additional measures 
included the number of days abstinent from substances, number of days worked and 
number of sessions attended.  Of the eight studies which involved additional outcomes to 
PTSD or substance misuse symptoms [23, 24, 25, 26, 27, 30, 31, 32], three [26, 30, 32] 
utilised only intrapersonal outcomes, and the remaining five [23, 24, 25, 27, 31] 
considered both interpersonal and intrapersonal outcomes together. 
 
4.1.5 Assessment of Outcomes 
The studies employed a range of assessment measures for substance use, including 
standardised self-report measures for substance use and PTSD symptoms in all ten of the 
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studies, and physical assessment measures involving urine toxicology screens in three of 
the studies [25, 26, 32].  When examining the use of measures in the trials, standardised 
measures were characterised by those for which information on psychometric properties, 
namely validity and reliability, were available.  Where this information was not adequately 
described in the studies themselves, attempts were made to identify this information 
through reference lists and electronic searching.  All of the studies utilised at least two 
standardised measures, four [25, 27, 28, 30] involved some measures which were not well 
validated or had no published information on psychometric properties, with the remaining 
six [23, 24, 26, 29, 31, 32] using standardised tools only or including an additional physical 
assessment measure.  It should also be noted that only three [28, 29, 32] of the ten 
studies included assessment of outcomes which were undertaken independently of the 
therapists delivering the intervention.   
 
4.2 Exploration of Methodological Heterogeneity 
An overview of the methodological heterogeneity of the trials is outlined in Table 1.2, 
which highlights large variability in the methodological quality of the trials.   
 
[Insert Table 1.2] 
 
4.2.1 General Findings 
Of the ten studies, five [23, 24, 25, 26, 30] employed a pre-post intervention measurement 
design, with the remaining five [27, 28, 29, 31, 32] reporting follow-up data.  Follow-up 
periods ranged from one week to twelve months and, of the five studies which included 
follow-up, the most frequent follow-up period was twelve months (N = 3).  
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4.2.2 Quality Criteria Assessment 
Of the ten studies, only two [29, 32] were rated as “Excellent,” a further four [23, 24, 27, 
28] were characterised as “Good,” two [25, 31] were classified as “Fair” and the remaining 
two studies [26, 30] were given a rating of “Poor” with the Quality Assessment Tool. 
 
4.2.3 Allocation to Intervention 
Although allocation to intervention was not applicable to over half of the studies included 
in the review, of the four RCTs identified in this review [23, 28, 29, 32] only one [29] 
specified appropriate allocation to intervention group, where the process of allocation was 
adequately described and carried out independently of the research team.  Of the three 
remaining RCTs, only one [28] - which shared the same data set as the RCT clarifying 
allocation procedures - gave partial information relating to allocation, and the remaining 
two [23, 32] did not provide any details about allocation.  
 
4.2.4 Data Analysis 
Of the ten studies, most [23, 24, 26, 27, 28, 29, 31, 32] reported appropriate data analysis 
and presented data adequately.  Attrition rates were stated for all ten of the trials, with 
three [25, 26, 31] reporting an attrition rate of zero.  Of the seven trials which involved 
attrition [23, 24, 27, 28, 29, 30, 32], three [23, 27, 32] included statistical analysis on 
attrition rates between groups.  Additionally, for the studies which specified attrition rates, 
four [23, 24, 27, 32] employed some form of intent to treat analysis. 
 
All of the studies reported statistically significant changes in identified outcomes. 
However, none reported effect sizes, and only one [29] considered results in the context 
of clinical significance.  In order to fully assess the clinical implications of the significant 
results reported in each of the studies, effect sizes were calculated using appropriate 
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methodology [38] where possible.  Table 1.3 provides an overview of reported results and 
corresponding effect sizes in each trial, indicating heterogeneity of results.   
 
[Insert Table 1.3] 
 
5.  Discussion 
5.1 General Findings 
This review represents a first attempt at employing a systematic approach to identifying 
the published literature on psychosocial interventions for co-morbid PTSD and substance 
misuse.  The review expands on previous narrative reviews in this area [17, 19] by 
undertaking standardised assessment of the quality of the evidence presented in the 
articles, with the aim of comparing these interventions.  However, when considering this 
evidence for the efficacy of these psychosocial interventions on, it should be noted that 
the studies employed a range of study designs and outcome measures, making 
comparisons between studies difficult. For example, the studies which examined broad 
categories of psychosocial interventions [23, 24] focussed on different aspects of 
functioning post-intervention.  Nevertheless, in general, each of the studies provided some 
evidence that a number of psychosocial interventions can improve PTSD, substance 
misuse, and both substance misuse and PTSD outcomes.   
 
5.2 Improvement in PTSD Outcomes 
Four studies [26, 27, 30, 32] reported improvements in PTSD outcomes, using both 
trauma focussed and non-trauma focussed interventions.   
 
For the studies which involved trauma focussed interventions [26, 27, 30], there is some 
evidence that psycho-education around trauma and recovery from trauma improved PTSD 
outcomes.  While the results presented [30] yielded small to medium effect sizes across 
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each of the domains of outcome, the poor methodological quality of this study should not 
be ignored. 
 
Of the remaining studies which examined trauma focussed interventions to improve PTSD 
outcomes [26, 27], both utilised Seeking Safety interventions.  The earlier study [26] 
identified improved post-intervention PTSD symptoms and quality of life, as well as self-
reported communication and problem-solving skills.  Some of the clear methodological 
difficulties of this study were subsequently addressed in a study which again detailed 
improvements in PTSD symptoms, particularly related to avoidance, intrusive thoughts 
and hyper-vigilance, during a twelve month follow-up period [27].  Moreover, the authors 
identified significant improvements in other psychological and social aspects of functioning 
during the follow-up period; however, the calculated effect sizes revealed that the 
magnitude of this improvement to be small across each of these domains. 
 
Additional high quality evidence [32] suggested that non-trauma focussed interventions, 
namely Contingency Management and Behavioural Therapy, can be effective in reducing 
the number and intensity of PTSD symptoms, as well as increasing levels of reported 
coping.  Unfortunately, it was not possible to calculate the corresponding effect sizes, 
given the available data.   
 
5.3 Improvement in Substance Misuse Outcomes 
There is reasonable evidence that interventions which are effective in managing 
substance misuse can also improve substance use outcomes for individuals with co-
morbid PTSD and substance misuse problems.  One study [31] indicated that a non-
trauma focussed intervention, specifically Behavioural Couples Therapy, can improve both 
substance misuse and general psychological functioning in this client group, with effect 
sizes ranging from small in substance use outcomes to medium in psychological 
  
 
 
24 
 
functioning.  While this study identified improvements over a twelve month follow-up 
period, caution should be used when considering these results due to the small sample 
size used in this study; an increased sample size would allow greater clarification of the 
effectiveness of this promising intervention. 
 
When comparing the utility of a number of psychosocial interventions for participants with 
co-morbid PTSD and substance use disorder with individuals affected by substance use 
disorder only [23], the authors noted that both groups improved across a range of 
substance misuse, psychological and interpersonal functioning outcomes during the 
intervention period and at six months follow-up, with a range of small to large effect sizes.  
However, those with co-occurring PTSD and substance misuse did not demonstrate the 
same level of improvement in substance misuse outcomes as those in the substance use 
disorder only group, and reported more severe problems across psychological and 
interpersonal domains at baseline and again at follow-up.  This finding suggests that 
clients with co-morbid PTSD and substance misuse experience higher levels of functional 
impairment, which may require more specialist intervention than would be typical with 
substance misuse alone.   
 
5.4 Improvement in Both PTSD and Substance Misuse Outcomes 
Attempts to determine whether specialist intervention for co-morbid PTSD and substance 
misuse is more effective than treatment as usual [24] identified improved outcomes in 
PTSD and alcohol use symptoms with Cognitive Behavioural Therapy (CBT), with 
consistently medium effect sizes across these domains.  While the umbrella term of CBT 
was applied, two distinct interventions which focussed on trauma (Seeking Safety) and 
substance misuse (Relapse Prevention) were employed in the trial.  This study did not 
identify any changes in measures of intrapersonal (i.e. depression and dissociation) 
functioning or interpersonal (i.e. social and sexual) functioning.  This result is not 
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surprising, given that the CBT interventions employed in these studies did not focus solely 
on these aspects of functioning.  However, if the hypothesis that individuals use 
substances to reduce negative affect is accurate [6, 7], this finding suggests that more 
comprehensive interventions may need to be developed and applied to this particular 
client group.   
 
Of the remaining studies which reported improvements in both PTSD and substance 
misuse symptoms [25, 29], both utilised Seeking Safety.  While clear methodological 
difficulties exist in the first study identifying improvements in both aspects of co-morbid 
PTSD and substance misuse [25], these difficulties have since been addressed by a study 
employing an RCT design and following up participants at one week and three, six and 
twelve months post-intervention [29].  With both of these studies, there was insufficient 
data to calculate effect sizes for these improvements.   
 
The later study [29] indicated that PTSD-related changes impact on substance use 
outcomes, with PTSD severity reductions being associated with substance use disorder 
improvements.  The authors also reported that Seeking Safety was more effective at 
achieving substance use disorder improvements than the psycho-educational control 
intervention, but only for individuals who reported heavier substance misuse at baseline 
and who achieved reductions in PTSD severity.  This finding indicates that trauma-
focussed interventions may only be of significant benefit to clients with more severe PTSD 
and substance misuse symptoms at baseline.  In addition to the reported improvements 
across substance misuse and PTSD domains in the studies which examined Seeking 
Safety, it has been reported that this type of trauma-focussed intervention is well tolerated 
by participants [28], as the study identified no additional intervention-related adverse 
psychological or substance use outcomes compared to a non-trauma focussed control 
intervention.   
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5.5 Mechanisms of Change 
While the studies included in this review identify a number of psychosocial interventions 
which can improve PSTD and substance misuse outcomes in individuals with these co-
morbid conditions, only one study [32] attempted to explore the mechanisms of change 
through which this improvement may occur.  While this study [32] did not include 
interventions which were specifically designed to address PTSD, the authors explored 
different coping styles (approach, negative and positive distraction coping) in relation to 
PTSD outcomes.  They reported that positive distraction coping predicted PTSD symptom 
and severity reductions, suggesting that interventions which aim to improve positive 
coping strategies may be of value for this client group.  This finding fits with the current 
evidence base for Cognitive-Behavioural interventions aimed at improving both PTSD [39] 
and substance misuse [40], independently of each other, and may explain why the 
interventions which move beyond psycho-education about trauma in an attempt to 
develop coping skills, such as Seeking Safety, provide the most compelling evidence for 
improving outcomes with this client group.  While the weight of the evidence in favour of 
Seeking Safety is likely to be influenced by the number of studies identified in this review 
(N=5), the methodological quality of studies examining this intervention type has improved 
from 2005 onwards, with the inclusion of RCTs and appropriate follow-up periods, 
allowing greater confidence in the evidence for this type of trauma-focussed intervention.   
 
5.6 Applying the Evidence 
Although this review has been able to identify a number of effective psychosocial 
interventions for co-occurring PTSD and substance misuse, some issues remain relating 
to the applicability of the results presented.  All of the research studies were undertaken 
by research groups in the USA, which has a unique healthcare system and is likely to 
have a different profile of substance misuse than other countries.  While reported 
prevalence rates of lifetime PTSD (30-58%) [41] and current PTSD (20-38%) [42] in 
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substance use disorder populations in the USA are comparable with those reported in a 
recent UK study (with lifetime PTSD 38.5% and current PTSD 51.9%) and a similar 
pattern of impairment exists in this population, it has been suggested that more research 
is needed on PTSD in substance misusing populations in the UK [8].  Undertaking 
additional research in countries outside the USA would allow greater worldwide 
applicability of the effective psychosocial interventions identified in this review. 
 
Additionally, when considering the evidence presented in this review, there should be 
some acknowledgement of the limitations of the methods employed.  These relate largely 
to the inclusion and exclusion criteria used, particularly the timescale for publication 
selected.  Although the search strategy identified no subsequent research on three of the 
interventions identified as promising in previous narrative reviews [17, 19] – Exposure 
Therapy [18], Substance Dependence Posttraumatic Stress Disorder Therapy [43], and 
Concurrent Treatment of PTSD and Cocaine Dependence [44] – there may have been 
value in assessing the quality of these earlier studies.  Furthermore, including only peer-
reviewed journal articles may have resulted in the omission of a number of potential 
studies, such as those published in book chapters.  This exclusion criterion was initially 
considered a useful screen for the quality of the articles selected; however, any evidence 
presented in these potential studies would have ultimately been weighted according to the 
Quality Assessment Tool.  Finally, as the Quality Assessment Tool focussed solely on 
information presented in the articles, the quality rating descriptor given may be the result 
of an absence of information, rather than the presence of methodological weaknesses in 
the studies. 
 
6.  Conclusions 
While there is evidence that psychosocial interventions designed to address co-morbid 
PTSD and substance misuse improve a range of PTSD-related and substance misuse 
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outcomes, as well as a number of additional psychological and social functioning 
outcomes, this review emphasises the large variation in the methodological rigour of the 
studies which support these interventions.  As it was not possible to combine calculated 
effect sizes across the studies in light of this variability, it is difficult to specify clear 
conclusions about the relative efficacy of the interventions presented in this review.  
Despite this, the review supports the findings of previous literature reviews in this area 
[17, 19] that a number of psychosocial interventions which are adapted from interventions 
for these problems occurring independently are effective for these co-morbid conditions.  
This review also lends further weight to the hypothesis that substances are often used as 
a means of coping with PTSD-related experiences [7], as it highlights the increased 
efficacy of coping-based interventions relative to interventions with an emphasis on 
psycho-education. 
 
In general, for trauma-focussed interventions [23, 24, 25, 26, 27, 28, 29, 30], the evidence 
for interventions which aim to develop coping skills [23, 24, 25, 26, 27, 28, 29] is of better 
quality than that presented in the study utilising psycho-educational interventions [30]. 
Moreover, the research consistently indicates that this type of intervention can improve 
both PTSD and substance misuse outcomes, occurring independently and together, and 
is well tolerated by individuals.  This fits the evidence which demonstrates that improving 
coping strategies can improve PTSD outcomes [32].  Furthermore, the evidence for non-
trauma focussed interventions [31, 32] suggests that the application of interventions which 
have not been developed solely for this co-morbid population can improve PTSD and 
substance misuse outcomes independently; however, whether these interventions could 
improve PTSD and substance misuse outcomes together has yet to be tested.  Given that 
there is some evidence, albeit of varying quality, for each of these interventions in relation 
to co-morbid PTSD and substance misuse, additional research is likely to increase 
confidence in the effectiveness of these interventions for this client group.  Since the 
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studies for some of these interventions, specifically Behavioural Couples Therapy, and 
Contingency Management and Behaviour Therapy, present first attempts to apply these 
interventions to co-occurring PTSD and substance misuse, it is plausible that subsequent 
research will improve on study design and quality, as is apparent in the increased number 
of studies with greater methodological rigour for Seeking Safety interventions.   
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Figure 1.  Overview of Search Strategy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Electronic Database Search: 
Ovid = 11, Web of Science (WoS) = 30 
Total initially identified and Abstracts 
reviewed = 41 
Website Search (Lisa Najavits):  
Total initially identified and Abstracts 
reviewed = 9 
Outcome of Search: 
Total Electronic Database Search = 8 
Total Reference List Search = 0 
Total Internet Searching = 2 
Total articles included in review = 10 
 
Website Search Excluded Articles: 
Non-intervention/ review article = 6 
Non-PTSD and substance misuse or 
non-adult population = 1 
Total remaining = 2 
 
Hand Searching Reference Lists: 
Total initially identified and Abstracts 
reviewed = 5 
Reference Lists Excluded Articles: 
Non-intervention/ review articles = 2 
Non-PTSD and substance misuse or 
non-adult population = 3 
Total remaining = 0 
 
Database Excluded Articles: 
Non-intervention/ review articles = 16 
Non-PTSD and substance misuse or non-
adult population = 17 
Total remaining = 8 (Ovid = 2, WoS = 6) 
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Table 1.1 Overview of Clinical Heterogeneity 
 
Study Study Type Population Sample Size Intervention Outcome Domains Outcome 
Measures 
Najavits, 
2007 
[23] 
Randomised 
Controlled 
Trial 
Cocaine-dependent 
men and women in 
community settings 
 Total N = 
428  
(PTSD-SU = 
34, SUD = 
394) 
 
Psychosocial interventions (Cognitive 
Therapy, Individual Supportive-
Expressive Therapy, Psychodynamic and 
12-step counselling) for PTSD and 
Substance Use (PTSD-SU) vs. Substance 
Use Disorder only (SUD) 
SUD symptoms 
Psychological functioning  
Interpersonal problems 
*ASI 
*BSI 
*IIP 
 
Cohen, 
2006 
[24] 
Controlled 
Trial 
Women in residential 
and community 
settings 
 Total N = 
107 
 (CBT = 75, 
TAU = 32) 
 
Cognitive-Behavioural Therapy (Seeking 
Safety and Relapse Prevention)(CBT) vs. 
Treatment as Usual (TAU) 
PTSD symptoms 
SUD symptoms 
Depression 
Dissociation 
Social functioning 
Sexual functioning 
*CAPS 
*ASI 
*HDRS 
*DES 
*DSBH (TSI) 
Najavits, 
2005 
[25] 
Uncontrolled 
Trial 
Men in community 
setting 
Total N = 5 Seeking Safety and Exposure Therapy 
Revised  
Attendance 
SUD symptoms 
Beliefs about SU and 
No. of 
attended 
sessions 
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PTSD 
Psychiatric problems 
Family and social 
functioning 
PTSD symptoms 
Urine 
toxicology  
*TSC-40  SBQ      
*BSI       *GAF               
TSR        *ASI 
WAS        SAS                                
*CGIS   BASU  
*CQS    SSFQ                      
*HAQ-II   PPQ    
CCQ  ET-RFQ 
Cook, 2006 
[26] 
Uncontrolled 
Trial 
Male and female 
veterans, Veteran 
Association 
outpatient setting 
Total N = 18 Seeking Safety PTSD symptoms 
Quality of Life 
 
*PTSDC-M        
*QOLI 
Urine 
toxicology  
Desai, 2008 
[27] 
Controlled 
Trial (pre-post 
non-
equivalent) 
Female, homeless 
veterans, Veteran 
Association 
outpatient settings 
Total N = 450 
(SS = 91, 
TAU = 359) 
Seeking Safety (SS) vs. Treatment as 
Usual (TAU) 
PTSD symptoms 
SUD symptoms 
Physical and mental 
functioning 
*SCL-21-R 
*SF-12   *ASI 
*PTSDC     
Self-esteem 
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Self-esteem 
Social support 
 
measure 
Social support 
No. of days 
worked 
Housing status 
Employment 
status 
Killeen, 
2008 
[28] 
Randomised 
Control Trial 
Women in 
community settings 
Total N = 353 
(SS = 176, 
WHE = 177) 
Seeking Safety (SS) + standard 
substance abuse treatment vs. Women’s 
Health Education (WHE) + standard 
substance abuse treatment 
Adverse Effects (AE): 
increased PTSD 
symptoms, increased 
depression symptoms, and 
increased or more severe 
alcohol or substance use.  
AEs categorised as “mild”, 
“moderate” or “severe.”  
*CAPS    *ASI            
SUI          AEQ           
*PSS-SR 
 
Hien, 2010 
[29] 
Randomised  
Control Trial 
Women in 
community settings 
Total N = 353 
(SS = 176, 
WHE = 177) 
Seeking Safety (SS) vs. Women’s Health 
Education (WHE) 
Improvements categorised: 
No response, Substance 
Use response, PTSD 
No. of days 
substances 
used in past 
  
 
 
40 
 
response or Global 
response (both Substance 
use and PTSD 
improvement).   
30 days 
*CAPS                  
*SUI         
*ASI-Lite 
Covington, 
2008 
[30] 
 
Uncontrolled 
Trial 
Women in residential 
setting 
Total N = 73 
(41 for 
analysis) 
Trauma-informed curricula:  Helping 
Women Recover (HWR) and Beyond 
Trauma (BT) 
PTSD symptoms 
Drug and alcohol usage 
Mental Health 
Criminal History  
*TSC-40         
*BDI      *ASI               
CQS     
Rotunda, 
2008 
[31] 
Controlled 
Trial 
Male veterans and 
non-substance using 
female partners, 
outpatient setting 
Total N = 38 
(PTSD-SU = 
19, SUD = 
19) 
Behavioural Couples Therapy for PTSD 
and Substance Use (PTSD-SU) and 
Substance Use Disorder only (SUD) 
Alcohol use 
Relationship functioning 
Psychological distress 
% days 
abstinent 
*CTS    *DrInC 
*MAST  *ADS      
* DAS              
*SCL-90-R  
Lester, 
2007 [32] 
Randomised  
Control Trial 
Cocaine-dependent 
homeless men and 
women, outpatient 
setting 
Total N = 118 
(CM+= 57, 
CM = 61) 
Contingency Management and Behaviour 
Treatment (CM+) vs. Contingency 
Management (CM) 
Coping Behaviours 
PTSD symptoms 
*Brief COPE  
*PDS              
Urine 
toxicology  
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Key: * Standardised assessment measure 
ADS – Alcohol Dependence Scale   AEQ – Adverse Events Questionnaire  ASI – Addiction Severity Index 
ASI-Lite – Addiction Severity Index-Lite   BASU – Beliefs About Substance Use  BDI – Beck Depression Inventory 
Brief COPE – Coping Orientations to Problems   BSI – Brief Symptom Inventory   CAPS – Clinician Administered PTSD Scale 
Experienced 
CCQ – Core Components Questionnaire  CGIS – Clinical Global Impressions Scale CSQ – Client Satisfaction Questionnaire 
CTS – Conflicts Tactics Scale    DAS – Dyadic Adjustment Scale   DES – Dissociative Experience Scale 
DrInC – Drinker Inventory of Consequences  DSBS – Dysfunctional Sexual Behavior Scale  ET-RFQ – Exposure Therapy-Revised Feedback 
             Questionnaire 
GAF – Global Assessment of Functioning  HAQ-II – Helping Alliance Questionnaire II HDRS – Hamilton Depression Rating Scale  
IIP – Inventory of Interpersonal Problems  MAST – Michigan Alcoholism Screening Test PDS – Post-Traumatic Diagnostic Scale 
PPQ – Patient Preferences Questionnaire   PSS-SR – Post-Traumatic Stress Disorder  PTSDC – PTSD Checklist    
       Symptom Self-Report  
PTSDC-M – PTSD Checklist-Military   QOLI – Quality of Life Inventory   SAS – Social Adjustment Scale 
SBQ – Suicidal Behaviors Questionnaire  SCL-21-R – 21-Item Symptom Checklist- SCL-90-R – Symptom Checklist  90-Revised 
       Revised 
SF-12 – 12-Item Short-From Survey   SQ – Safety Questionnaire   SSFQ – Seeking Safety Feedback  
       Questionnaire 
SUI – Substance Use Inventory    TSC-40 – Trauma Symptom Checklist-40 TSI – Trauma Symptom Inventory  
TSR – Treatment Services Review   WAS – World Assumptions Scale 
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Table 1.2 Overview of Methodological Heterogeneity 
Study Follow-Up Changes Quality 
Criteria 
Assessment 
Allocation  Attrition Rates Specified Intention to 
Treat Analysis 
Clinical 
Significance 
Najavits, 
2007 [23] 
Pre- and 1-6 months intervention 
assessment (pre- and post-
intervention assessment) 
Good Not specified Yes – SUD-PTSD 76.5 %, SUD only 
68% 
No significant difference between groups   
Yes – Mixed 
pattern analysis  
No 
Cohen, 
2006 [24] 
Pre- and post-intervention 
assessment 
Good N/A Yes – 25% drop out Yes – Last 
Observation 
Carried 
Forward 
No 
Najavits, 
2005 [25] 
Pre- and post-intervention 
assessment 
Fair N/A No attrition N/A No 
Cook, 2006 
[26] 
Pre- and post-intervention 
assessment 
Poor N/A No attrition 
 
N/A No 
Desai, 2008 
[27] 
Pre- and post-intervention, and 3, 
6, 9 and 12 months follow-up 
 
Good N/A Yes – 15-20% at 3 months, 33-37% at 6 
months, 44-60% at 9 months and 47-
73% at 12 months 
No significant difference between groups 
Adjustment for 
participants lost 
to follow-up 
made with 
No 
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at 6 and 9 months  interaction 
between 
baseline 
measure and 
time 
Killeen, 
2008 [28] 
 
 
Baseline, weekly questionnaires 
and 1 week follow-up 
Good Partially 
specified 
Yes – 18% dropped out before 
intervention, 13% dropped out due to 
any AEs, 15% due to study-related AEs 
and 3 patients due to clinician-rated 
deterioration 
No No 
Hien, 2010 
[29] 
Baseline, weekly questionnaires 
and 1 week, 3 months, 6 months 
and 12 months follow-up 
Excellent Stratified by 
prescription 
psychotrophic 
medication 
and substance 
use diagnosis 
Yes – 56% Completers (+ 6 sessions) No Yes – 
improvement 
defined as 
30% greater 
from baseline 
to each 
intervention 
phase 
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Covington, 
2008 [30] 
Assessment at 5 time points: 
intake, stabilisation period of 45 
days, completion of HWR, 
completion of BT and exit (pre- 
and post-intervention 
assessment) 
Poor N/A Partial – data available to analyse:  
Baseline (N = 195-199), exited 
programme (N = 79-84), post-
intervention (N = 40-44) 
No No 
Rotunda, 
2008 [31] 
 
 
Pre- and post-intervention, and 
12 months follow-up 
Fair N/A No attrition N/A No 
Lester, 
2007 [32] 
Pre-intervention, 2 months and 6 
months follow-up 
Excellent Not specified Yes – at 6 months, attrition 30% for CM 
vs. 26% CM+ group  
No significant difference between groups 
Yes – 
Expectation-
Maximisation 
algorithm for 
missing data 
No 
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Table 1.3 Overview of Reported Results and Calculated Effect Sizes  
 
Study Results: p-values and Calculated Effect Sizes (ES) Interpretation of Results 
 
Najavits, 
2007 [23] 
Significant effect for PTSD status:  
ASI Family-Social (ES=0.9, large), Medical (ES=0.39, small) and Psychiatric (ES=0.66, large) 
BSI Global Severity (ES =1.52, large) 
IIP (ES=0.96, large) 
Significant effect for Time:  
ASI Drug (ES=3.32, large), Alcohol (ES=1.23, large), Family-Social (ES=1.44, large), 
Employment (ES=0.52, medium) and Psychiatric (ES=1.11, large) 
 BSI Global Severity (ES=1.63, large) 
 IIP (ES=0.68, medium) 
Significant PTSD x Time interaction:  
ASI legal (ES=0.45, medium) 
Estimates of ES for within-group changes not possible 
SUD-PTSD group with greater 
impairment across domains than SUD-
only group over time.  Patients improved 
across 7 domains over 6 month period.   
SUD-PTSD group with worse 
psychological and interpersonal 
functioning at baseline and follow-up, 
also reported more addiction-related 
medical problems. 
Cohen, 2006 
[24] 
Significant effect for Treatment:  
CAPS (ES=0.6, medium) 
 ASI Alcohol (ES=0.61, medium) 
CBT interventions significantly reduced 
PTSD and alcohol use disorder 
symptoms. 
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Significant effect for Severity:  
CAPS (ES=1.18, large) 
ASI Alcohol (ES=2.06, large), Drug (ES=1.92, large) and Social (ES=1.54, large) 
HAM-D (ES=1.4, large) 
DES (ES=1.54, large) 
TSI-DSB (ES=1.26, large) 
Najavits, 
2005 [25] 
Significant improvements:  
ASI Drug (p=0.05) and Social-Family (p=0.05) 
TSC-40 Trauma Symptoms (p=0.03), Anxiety (p=0.04), Dissociation (p=0.03) and Sexual Abuse 
Trauma (p=0.04) 
GAF Overall Functioning (p<0.02) 
BSI Hostility (p<0.04) 
WAS Meaningfulness (p<0.01) 
SQ Safety Feelings (p<0.04) and Thoughts (p<0.000) 
Urinalysis consistent with self-report measures 
No control condition to calculate ES 
SS intervention with improvements in 
drug use, social and family functioning, 
trauma symptoms, anxiety, dissociation, 
sexual abuse index, overall functioning, 
hostility, meaningfulness, and feeling and 
thoughts relating to safety. 
Level of satisfaction, alliance, attendance 
and retention strong. 
Cook, 2006 
[26] 
Significant improvements: 
PTSD C-M (p<0.001) 
PTSD and QOL improved, with reported 
improvements in communication and 
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QOL (p<0.05) 
No control condition to calculate ES 
problem-solving skills. 
Desai, 2008 
[27] 
Significant effect for Seeking Safety:  
Days worked in past 30 days (ES=0.37, small) 
Social support (ES=0.26, small) 
SCL-21-R (ES=0.25, small) 
PTSD Checklist (ES=0.26, small), Avoidance (ES=0.32, small) and Hyper-vigilance (ES=0.24, 
small)  
ASI psychiatric (ES=0.26, small) 
Significant effect for Time:  
Number of days in past 30 days: worked (ES=0.62, medium), homeless ES=0.23, small), drug 
use (ES=0.19, small) and alcohol use (ES=0.49, medium)  
Social support (ES=0.63, medium) 
SCL-90-R (ES=0.5, medium) 
PTSD Checklist (ES=0.49, medium), Avoidance (ES=0.54, medium), Intrusive Thoughts 
(ES=0.56, medium) and Hyper-vigilance (ES=0.48, medium) 
ASI Psychiatric (ES=0.42, medium), Drug (ES=0.47, medium) and Alcohol (ES=0.49, medium) 
 SF-12 Mental (ES=0.43, medium) and Medical (ES=0.59, medium)  
Over 12 months follow-up, SS group with 
significantly greater improvement in 
psychiatric and PTSD symptoms and 
social support. 
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Killeen, 
2008 [28] 
Significant effect for Attended Sessions: 
Adverse Events (p=0.01) 
Fewer study-related AEs associated with: 
More cocaine (p<0.002) and alcohol (p<0.003) use in 30 days prior to baseline  
Higher total CAPS, C and D at baseline (p<0.0001) 
Past 30 day cocaine use post-intervention(p=0.03) 
Significant intervention x study-related AEs interaction:  
Past 30 day opiate (p=0.03) and marijuana (p-0.04) use at post-intervention 
Insufficient raw data to calculate ES 
SS intervention no difference in 
treatment-related AEs to WHE 
intervention, so addressing trauma well 
tolerated.  In both group, more treatment 
sessions related to more study-related 
AEs. 
Hien, 2010 
[29] 
Significant Effect of PTSD Improvement: 
Change in CAPS from baseline to each follow-up point (p<0.005) 
Three-way treatment group x baseline substance use x PTSD improvement interaction:  
PSTD improvement impact on substance use at follow-up significantly differed by treatment 
group and baseline level of drug use (maximum days use p=0.02; drug composite p=0.03) 
Two-way CAPS improvement x baseline alcohol use interaction: 
For baseline heavy substance users, impact of improved CAPS scores differed significantly by 
treatment group (p=0.003) 
Insufficient raw data to calculate ES 
PTSD severity reduced significantly and 
improved substance use outcomes.  
Seeking Safety improved substance use 
outcomes in heavy substance users with 
reduced PTSD outcomes.   
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Covington, 
2008 [30] 
Baseline to HWR: 
Significant effect – TSC-40 Depression (ES=0.4, medium) and Sleep Disturbance (ES=0.41, 
medium) 
HWR to BT: 
Significant effect – TSC-40 Anxiety (ES=0.3, small), Dissociation (ES=0.34, small), Depression 
(ES=0.52, medium) and Sleep Disturbance (ES=0.51, medium) 
Scores on TSC-40 significantly improved 
after completing HWR and BT. 
HWR & BT with greater improvement 
than BT alone. 
Rotunda, 
2008 [31] 
Significant effect for Time:  
% days abstinent (ES=0.23, small) 
Drinker Inventory of Consequences (ES=0.25, small) 
Dyadic Adjustment Scale (ES=0.26, small) 
SCL-90-R (ES= 0.47, medium) 
Each measure indicated improvement 
from pre- to post-intervention, and at 12 
months follow-up.  Pattern of change 
similar for PSTD and non-PTSD group. 
Lester, 2007 
[32] 
Approach coping:   
Gender main effect (p<0.05) - women with more approach coping 
Negative avoidance coping:  
Significant time x gender interaction (p<0.05) - men declining faster 
Positive distraction:  
Group main effect (p<0.05) - CM+ reporting higher levels of coping 
Gender main effect (p<0.05) - women reporting higher level of coping  
CM+ with fewer PTSD symptoms and 
less severity than CM. 
CM+ with higher levels of reported 
coping. 
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Time x group interaction (p<0.05) - CM+ showing decline in positive distraction and CM group 
showing increase in positive distraction 
PTSD:  
Group main effect (p<0.05) - CM+ with fewer and less severe PTSD at 6 months  
Baseline negative avoidance, positive distraction and change in negative avoidance predictive of 
PTSD symptoms at 6 months (ps<0.05) 
Insufficient raw data to calculate ES 
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Objectives:  Previous research has identified negative staff attitudes towards patients 
who self-harm, as well as stigma towards mental health problems in general hospital 
settings.  This study extended this existing research to patients who present to general 
hospital settings with self-harm by measuring their perceptions of stigma in comparison 
with a control group of other hospital patients.  The study also examined whether 
perceived stigma was related to aspects of current psychological distress. 
 
Method:  Ten patients who were admitted to hospital following an episode of self-harm 
and ten hospital control patients completed a demographic questionnaire, the SCL-90-R 
measure of current psychological distress and a purpose-designed measure of perceived 
stigma. 
 
Results:  Mann-Whitney U-tests revealed significant differences on SCL-90-R 
Interpersonal Sensitivity (U=17.50, p=0.011), Paranoid Ideation (U=21.00, p=0.029) and 
Psychoticism (U=23.00, p=0.043), together with marginally significant differences on 
Depression (U=24.50, p=0.052) and Hostility (U=24.50, p=0.052), between the two 
groups.  A significant difference in perceived stigma scores (U=16.00, p=0.009) was also 
identified.  One-tailed Spearman’s correlations highlighted positive associations between 
perceived stigma and SCL-90-R Interpersonal Sensitivity (ρ=0.685, p=0.014) and 
Depression (ρ=0.723, p=0.009) in the self-harm group, and SCL-90-R Depression 
(ρ=0.596, p=0.035) and Phobic Anxiety (ρ=0.595, p=0.035) in the control group. 
 
Conclusions:  The results suggested that patients who self-harm perceive higher levels 
of stigma in general hospital settings compared to patients presenting with other types of 
injury.  These differences appeared to relate to aspects of current psychological distress.  
Further research employing larger samples would help clarify this association. 
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1.  Introduction 
1.1 Mental Health Stigma in Healthcare Settings 
Stigma has been defined as “an attribute that extensively discredits an individual, reducing 
him or her from a whole and usual person to a tainted or discredited one” (Goffman, 1963, 
p. 3).  Stigma has been identified in individuals with a number of physical health 
conditions which are considered to: cause behaviours perceived as unusual or frightening 
(including epilepsy and Tourette’s Syndrome); reflect personal inadequacy (such as drug 
dependence and obesity); result from perceived immoral behaviour (for instance, HIV and 
AIDS); and impact on private or embarrassing body parts (including urological conditions 
and faecal incontinence) (West & Hardy, 2007). The experience of stigma has been 
investigated in those with mental health problems, particularly in the context of healthcare 
settings, as mental ill-health is often considered to hold a shameful quality (Pompili, 
Girardi, Ruberto, Kotazalidis & Tatarelli, 2005).  There is also considerable evidence that 
the physical health problems of those with mental health problems are frequently under-
diagnosed and inappropriately treated (Kuey, 2008), and that the identification of a mental 
health problem influences clinical-decision making in healthcare settings.  For example, a 
recent study (Peris, Teachman & Nosek, 2008) examined implicit and explicit biases 
towards people with mental health problems in healthcare professionals with different 
levels of mental health training.  These authors used a vignette-based method to explore 
clinical decision-making and reported that biases predicted clinical decision-making, with 
explicit bias acting as a significant predictor of negative prognosis, and implicit bias 
relating to over-diagnosis.   
 
1.2 Healthcare Staff and Mental Health Stigma 
In their study exploring the stigmatising experiences of patients with mental health 
problems in general hospital settings, Liggins and Hatcher (2005) identified a number of 
salient stigma-related themes from staff relating to fear, hopelessness, labelling and 
  
 
 
54 
 
disbelief in illness.  These researchers noted that these themes are pervasive in the 
general population and suggest that in general medical settings there exists an additional 
perception that the patient is not genuinely ill.   
 
Ross and Goldner (2009) undertook a comprehensive review of the role of nursing staff in 
mental health stigma and again identified negative staff attitudes and pervasive themes of 
fear, blame and hostility towards those with mental health problems, stating that these 
attitudes have a significant impact on the quality of care provision.  When considering the 
reasons underlying these attitudes, the authors suggested that fear of these patients may 
relate, in part, to stereotypes common within the general population.  Moreover, these 
authors noted that staff often feel de-skilled and ill-equipped to manage and support these 
individuals.  They concluded that nursing staff can play a valuable role in de-stigmatising 
these patients and acting as advocates on their behalf.   
 
1.3 Understanding Self-Harm 
An act of self-harm is one which involves deliberately inflicting pain or injury to one’s own 
body; it is usually an attempt to stay alive in the face of great emotional pain (Arnold & 
Magill, 2001).  While research consistently indicates an elevated risk of suicide for 
individuals who frequently self-harm, with estimates of up to 30 times greater risk of 
suicide (Cooper et al., 2005), self-harm is frequently characterised by an absence of 
suicidal intent.  To illustrate, a recent survey of adolescent self-harm in Scottish 
populations reported similar prevalence rates to those found in England, despite Scotland 
having a suicide rate twice as high as England (O’Connor, Rasmussen, Miles & Hawton, 
2009).  Although there are a range of descriptive terms used for different kinds of self-
inflicted injury, NICE (2004, pg 16) conceptualises self-harm as “self-poisoning or self-
injury, irrespective of the apparent purpose of the act.” These guidelines again highlight 
that acts of self-harm are often expressions of personal distress. 
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A review of risk factors for self-harm (Gratz, 2003) highlighted a number of factors relating 
to childhood trauma, including childhood sexual and physical abuse, neglect and a 
disruption in the quality and security of attachment relationships.  This review also clarified 
some of the functions of self-harm, such as representing a strategy for affect regulation.  
In this respect, self-harm may play a role in reducing anxiety, externalising emotional pain 
and regaining control over problematic thoughts and feelings.  The link between adverse 
childhood experiences and self-harming behaviour in later life was again identified in a 
prospective study on the consequences of childhood sexual abuse by Yates, Carlson and 
Egeland (2008), who noted that childhood trauma results in impoverished ways of 
managing emotion and affect.  In addition to the use of self-harm as a strategy to regulate 
affect, it has been suggested that those who self-harm frequently use their body as a 
mode to communicate emotional pain to others (Potter, 2003). This strategy, however, 
often has a paradoxical effect on both clinicians and members of the general public, as 
self-harming behaviour frequently arouses hostile and negative reactions in others 
(Barstow, 1995).   
 
1.4 Healthcare Experiences for Individuals who Self-Harm 
The Royal College of Psychiatrists (2006) recently undertook a national audit, service 
evaluation and quality improvement initiative for individuals who self-harm, and reported a 
high variation in the quality of care provision for these patients.  This report also advised 
that general medical staff often feel unskilled and poorly informed as to how to support 
these patients (Blackwell & Palmer, 2008).  Recent NICE Guidelines (2004) on the short-
term management and secondary prevention of self-harm state that self-harming patients 
have the same right to healthcare as all other patients.  Nevertheless, individuals who 
attend healthcare services with self-harm frequently report that they perceive rejection, 
hopelessness and an absence of empathy in clinicians (Harris, 2000).  McAllister, Creedy, 
Moyle and Farrugia (2002) noted that in Accident and Emergency (A&E) departments 
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where cases are prioritised according to life threat, those who self-harm are frequently 
ignored and made to wait for long periods.  These authors suggested that these patients 
frequently recognise rejection during their contact with healthcare staff, which can lead to 
further self-harming behaviour.  In addition to both objective and perceived differences in 
health care provision, a large body of research has identified negative attitudes towards 
self-injury from healthcare staff.    
 
1.5 Staff Attitudes to Self-Harm 
Misunderstandings about purpose of self-harm are common in healthcare settings. For 
example, Shaw (2002) suggested that healthcare staff frequently view self-harm as a form 
of psychological blackmail, rather than as an attempt by the individual to control their 
distress.  Additionally, Friedman et al. (2006) examined the factors which predict the 
attitudes of A&E staff to patients who self-harm, and reported that staff recognised self-
harm as a significant problem, but felt unskilled and under-resourced when dealing with 
this issue.  Moreover, a large proportion of A&E staff respondents (80%) conceptualised 
self-harm as attention-seeking and manipulative behaviour, rather than as individuals 
seeking appropriate medical attention.   
 
Since many healthcare professionals believe that individuals who self-harm do so from a 
specific volition to die (Ross & Goldner, 2009), these patients are often perceived as 
having a reduced entitlement to medical care.  Furthermore, Hopkins (2002) reported that 
nursing staff frequently believe self-harming individuals to be impeding the functioning of 
medical admissions units due to the complexity of their presentations and time-consuming 
needs.    
 
When considering the reasons for negative staff attitudes towards self-harm, Johnston 
and Cowman (2008) noted a shift in the provision of psychiatric services to community 
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settings and suggested that the increased numbers of mental health patients presenting to 
general hospital settings has resulted in changing roles and functions for general 
healthcare staff. Moreover, Summers and Happell (2003) described a clash of cultures 
between traditional staff roles where the emphasis has previously been on caring for 
acutely physically unwell patients, and new expectations of working with individuals who 
would previously have been seen within psychiatric services.  In their study of patient 
satisfaction with psychiatric services provided by hospital emergency departments, these 
authors reported that staff felt overwhelmed by expectations that they provide acute 
psychiatric services, while patients felt unwelcome because their presenting needs were 
not prioritised.   
 
While this shift in service provision and expectations of medical staff in hospital settings 
may partially explain the negative staff attitudes towards self-harming patients in 
emergency medical settings, a recent review by Pompili et al. (2005) linked these 
responses to underlying stigma.  The authors suggested that healthcare staff fear patients 
who self-harm, as they are involved in a self-annihilation process which runs counter to 
the nature of medical training and usual clinical practice where healthcare staff interact 
with patients desiring the maintenance of health.    
 
1.6 Study Aims and Hypotheses 
1.6.1 Study Aims  
The present study aimed to extend previous research on mental health stigma in general 
medical settings to patients who present to these settings with self-harm.  Given the 
evidence which indicates that these patients perceive negative responses from staff, and 
the suggestion that these responses may relate to stigma, this study specifically 
attempted to measure the perception of stigma in individuals presenting with self-harm.  
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This study also compared the perceptions of stigma in individuals presenting with self-
harming behaviour with a control group of other hospital patients.  Finally, this study 
examined whether perceptions of stigma were related to current level of psychological 
distress, since Klonsky, Oltmanns and Turkheimer (2003) identified a greater presence of 
personality disorders and related personality traits, particularly a tendency towards intense 
emotions and a heightened sensitivity to rejection, in a non-clinical sample of self-harming 
military recruits.   
 
1.6.2 Study Hypotheses 
It was hypothesised that:  
 
1) Patients presenting with self-harm would report greater levels of perceived stigma than 
hospital control patients on a purpose-designed measure of perceived stigma.  
 
2) Greater perceptions of stigma would correlate with self-reported levels of psychological 
distress, as measured by the SCL-90-R. 
 
3) Positive correlations would exist between perceived stigma and Primary Symptom 
Dimensions of Paranoid Ideation and Interpersonal Sensitivity on the SCL-90-R.   
 
2.  Methods  
2.1 Design  
The study used a cross-sectional, between-groups design to compare patients presenting 
with self-harm with a control group of other hospital patients.  The independent variable 
was self-harm status, i.e. admitted to hospital for self-harm versus admitted to hospital for 
any other reason.  The dependent variables were current psychological distress, as 
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measured by the SCL-90-R, and perceptions of stigma on a purpose-designed measure. 
The primary dependent variable was perceived stigma.   
 
2.2 Power Calculation  
During the development of the research study, a power calculation was performed using 
data from research with people who self-harm using the SCL-90-R measure (Sarno, 
Madeddu & Gratz, 2009).  This study reported significant differences for three groups of 
participants on the global distress index, Positive Symptom Total (PST), of SCL-90-R 
between: 1) those who do not self-harm (No Self-Harm); 2) those who self-harm 
episodically (Episodic Self-Harm); and 3) those who self-harm repeatedly (Recurrent Self-
Harm).  Effect sizes of 0.46 for the No Self-Harm and Episodic Self-Harm groups, and 
1.07 for the No Self-Harm and Recurrent Self-Harm groups were calculated.  As the 
present study did not distinguish between episodic and repeated self-harm, an average 
effect size of 0.76 was calculated.  Setting the alpha level at 0.05 and power at 0.8, the 
power calculation indicated that a total sample of 46 participants – with 23 in each group – 
was required. 
 
2.3 Inclusion and Exclusion Criteria 
Participants were eligible to take part in the study if they were aged over 16 years and 
admitted to the emergency receiving ward at a general hospital following an incident of 
self-harm or any other physical health problem or non-deliberate injury.  Participants were 
excluded from the study if unfit for interview due to their current physical or psychological 
state, unable to give informed consent, or did not speak English as a first language.   
 
2.4 Ethics 
This study was carried out following the Guidelines for Minimum Standards of Ethical 
Approval in Psychological Research (British Psychological Society, 2004).  NHS Research 
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Ethics Committee approval was obtained for four hospital sites within NHS Greater 
Glasgow and Clyde.  However, unanticipated NHS managerial constraints at these sites 
meant that recruitment was only undertaken at one of the proposed hospital sites. 
 
2.5 Procedure 
2.5.1 Recruitment  
Participants were recruited from the emergency receiving ward through the local Liaison 
Psychiatry Service (LPS).  The principal researcher contacted the LPS team to enquire 
whether they had received any referrals for self-harm at the identified hospital base.  Staff 
from LPS identified appropriate individuals who were then approached by the principal 
researcher after completing a “treatment-as-usual” routine risk assessment with LPS.  
Individuals in the control group were matched by gender, age and socio-economic status, 
as closely as possible, to those in the self-harm group and were approached directly by 
the principal researcher.  All participants were fully informed about the purpose and 
process of the research, both verbally and in writing through the Participant Information 
Sheet (Appendix 2.2), and gave their written consent to participate prior to data collection 
(Appendix 2.3).   
 
2.5.2 Data Collection 
Both groups of participants were given a questionnaire pack to be returned directly to the 
principal researcher, by posting questionnaires in a sealed box on the ward or by using a 
freepost envelope with which they were provided.  
 
2.6 Measures 
2.6.1 Demographic Questionnaire 
All participants completed a demographic questionnaire (Appendix 2.4) which collected 
standard demographic information, including age, gender, ethnicity, employment status 
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and years in full-time education.  Socio-economic status was subsequently determined by 
using the Standard Occupational Classification (SOC2000) (Great Britain Office for 
National Statistics, 2000) for stated job title. 
 
Information was also collected on the reason for attending hospital and on whether the 
injury was sustained whilst intoxicated.  Individuals who attended hospital for self-harm 
completed two further self-harm specific questions relating to the method of self-harm, 
and previous hospital attendance for self-harm.   
 
2.6.2 Symptom Checklist-90-R (SCL-90-R) (Derogatis, 1994)  
Current psychological state was measured by the SCL-90-R, which evaluates nine 
Primary Symptom Dimensions: Somatisation, Obsessive-Compulsive, Interpersonal 
Sensitivity, Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation and 
Psychoticism.  This measure also examines three indices of global distress: Global 
Severity Index (GSI); Positive Symptom Distress Index (PSDI); and Positive Symptom 
Total (PST).   
 
Internal consistency of the SCL-90-R is satisfactory, with coefficients ranging from low 
(r=0.77) to high (r=0.90), and test-retest reliability is high (Cronbach’s α=0.80-0.90) for 
symptom constructs (Derogatis, Rickels and Rock, 1976).  The SCL-90-R has normative 
data for adult non-patients, psychiatric outpatients and inpatients, and adolescent non-
patients. 
 
2.6.3 Measure of Perceived Stigma  
As standardised measures of perceived mental health stigma (e.g. King et al., 2007) were 
deemed unsuitable for both groups of participants in the study, a purpose-designed 
measure based on current research evidence was developed.  The measure examined 
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three broad areas relating to negative staff attitudes towards self-injury (McAllister et al., 
2002): 1) emotional responses of staff (for example, feelings of anger, fear and frustration 
towards patients); 2) objective experiences (such as increased waiting times and painful 
treatment); and 3) professional conduct of staff (including making negative comments and 
not treating injuries as genuine).  This Likert scale (Appendix 2.5) included five items from 
each of these three areas (a total of 15 items), which were counterbalanced by an equal 
number (15) of positive and neutral statements.  Participants rated each of these 30 items 
on a five-point scale from “Strongly Disagree” to “Strongly Agree,” with reverse scoring for 
the positive and neutral statements.  The scoring range was 0-120, with a higher score 
indicating a higher level of perceived stigma.   
 
After data collection, the internal reliability of this measure was assessed using 
Cronbach’s Alpha (α=0.983).  
 
2.7 Coding of SCL-90-R Data 
It should be noted that different normative data were applied to the two groups of 
participants when converting raw scores to normative T-scores on the SCL-90-R 
measure.  Although the study did not collect information on current contact with 
psychiatric services, norms for adult psychiatric outpatients were applied to individuals in 
the self-harm group, as the raw scores were consistently beyond the data available for 
adult non-patients.  For individuals in the control condition, the T-scores used were those 
for non-patients and, where raw scores were greater than those available for this 
category, the highest available T-score was used.  For example, a raw score of 3.17 for 
the Somatisation index was beyond the range of normative data for non-patients, and was 
consequently given the highest possible T-score of 81.   
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2.8 Data analysis 
Preliminary data screening revealed that the data for two of the SCL-90-R Primary 
Symptom Dimensions (Somatisation and Anxiety), and two indices of global distress (GSI 
and PST) were skewed.  The perceived stigma scores were also skewed.  Apart from the 
problem of skewness, the small number of participants in both groups indicated that it was 
appropriate for non-parametric tests to be used.  
 
Mann-Whitney U-tests were conducted on demographic variables of age and years in 
education in order to ensure that the groups were similar enough for comparisons to be 
made.  Preliminary analyses revealed the data for employment status, SOC2000 category 
and socio-economic class violated assumptions for Chi-Squared analyses, meaning that 
these data were visually inspected for appropriate matching.  A series of Mann-Whitney 
U-tests was also undertaken to compare the two groups on each index of the SCL-90-R 
measure and perceived stigma score.  The SCL-90-R Global Severity Index (GSI) is cited 
as the best single indicator of current psychological distress, and was therefore used for 
one-tailed Spearman’s Correlation analyses with perceived stigma score, along with each 
SCL-90-R Primary Symptom Dimensions, for those in both the self-harm and the control 
group.   
 
3.  Results 
3.1 Demographic Characteristics of Participants  
During the 18-week recruitment period, a total of 44 self-harming patients were referred to 
LPS after admission to the general receiving ward.  After applying the exclusion criteria 
and discussing suitability with LPS staff, 15 individuals were approached and consented 
to participate in the study.  Of these 15, four individuals did not complete the 
questionnaires provided and one withdrew consent during participation, leaving ten 
  
 
 
64 
 
participants in the self-harm group.  Correspondingly, ten control participants were 
recruited to the study.   
 
Demographic characteristics for all participants, and categorised by group, are shown in 
Table 2.1.   
 
[Insert Table 2.1] 
 
Table 2.1 also reports the Mann-Whitney U-tests which revealed no significant differences 
between the groups with regard to age (U=36.5, p=0.315) and years in education 
(U=26.0, p=0.075), indicating that the groups were appropriately matched on these 
variables.  Visual inspection of the data for employment status, SOC2000 Classification 
and socio-economic class also suggested appropriate matching of the groups.   
 
Additional information is presented in Table 2.2 relating to the reason for attending 
hospital or method of self-harm, to whether this injury occurred while the individual was 
intoxicated and, for those in the self-harm group, to whether they had previously attended 
hospital for self-harm.   
 
[Insert Table 2.2] 
 
It should be noted, however, that the reasons for attending hospital given by the control 
group could not be corroborated by accessing medical records or the opinions of 
attending medical staff due to confidentiality considerations.   
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3.2 Clinical Characteristics of Participants 
The median scores and range for each of the SCL-90-R Primary Symptom Dimensions 
and indices of global distress are presented in Table 2.3.   
 
[Insert Table 2.3] 
 
In addition to issues relating to skew and to the small sample size, the standard deviations 
for the control group identified during preliminary data screening were much larger than 
for the self-harm participants, indicating greater variability in their responses.  As such, a 
series of Mann-Whitney U-tests was used to compare each of the nine SCL-90-R primary 
and three indices of global distress between the groups.  The results presented in Table 
2.3 indicate significant differences on Interpersonal Sensitivity (U=17.50, p=0.011), 
Paranoid Ideation (U=21.00, p=0.029) and Psychoticism (U=23.00, p=0.043) between the 
self-harm and the control group.  There were also marginally significant differences for 
Depression (U=24.50, p=0.052) and Hostility (U=24.50, p=0.052) between the two groups. 
No significant differences were identified on any of the global distress indices on the SCL-
90-R between the groups.    
 
3.3 Experimental Data  
3.3.1 Differences in Perceived Stigma 
Table 2.3 presents median scores and range for the two groups on the measure of 
perceived stigma.  A further Mann-Whitney U-test identified a significant difference 
between the perceived stigma score for the groups (U=16.00, p=0.009), suggesting that 
those in the self-harm group reported greater levels of perceived stigma than those in the 
control group. 
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3.3.2 Correlations between SCL-90-R and Perceived Stigma 
One-tailed Spearman’s Correlations were undertaken between each of the SCL-90-R 
Primary Symptom Dimensions, SCL-90-R GSI and perceived stigma scores for the self-
harm and the control groups, as presented in Tables 2.4 and 2.5. 
 
[Insert Tables 2.4 and 2.5].   
 
As indicated in these tables, perceived stigma was not correlated with current global 
psychological distress, as measured by the SCL-90-R GSI for either group.  Perceived 
stigma was, however, positively associated with SCL-90-R Interpersonal Sensitivity 
(ρ=0.685, p=0.014) and Depression (ρ=0.723, p=0.009) in the self-harm group, as 
indicated in Table 2.4.  This finding suggested that the third hypothesis, stating that 
perceived stigma would be associated with Interpersonal Sensitivity and Paranoid Ideation 
on the SCL-90-R, was partially upheld.  Additionally, perceived stigma was correlated with 
Depression (ρ=0.596, p=0.035) and Phobic Anxiety (ρ=0.595, p=0.035) for the control 
group. 
 
4.  Discussion 
4.1 Overview of Results 
While a large body of research has focussed on staff attitudes to self-harm (e.g. Friedman 
et al., 2006), or explored patients’ perceptions of their treatment in hospital (e.g. McAllister 
et al., 2002), this study was the first to attempt to measure perceived stigma in individuals 
who present to general hospital settings with self-harm in comparison with a control group 
of other hospital patients.  The results reveal that participants in the self-harm group 
reported higher levels of perceived stigma than those in the control condition.  This finding 
suggests that patients who present to general hospital settings with self-harm hold 
different perceptions of their healthcare experiences to other types of patients.  Moreover, 
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perceptions of stigma were related to aspects of psychological distress for both self-
harming and non self-harming patients.  This relationship was more pronounced for 
individuals presenting with self-harm. 
 
4.2 Representativeness of the Sample 
The sample used in this research represents a similar profile to that reported in other 
research studies investigating self-harm within general hospital settings.  Participants in 
this study overwhelmingly engaged in overdose as a method of self-harm, which is 
consistent with the 80% of self-harming patients presenting to hospital settings due to self-
poisoning identified by Horrocks et al. (2003). A recent review of attitudes to clinical 
services among those attending hospitals for self-harm again highlighted that most 
individuals who present to these settings do so after an episode of self-poisoning (Taylor, 
Hawton, Fortune & Kapur, 2009), so it is unsurprising that the majority of study 
participants engaged in this form of self-harming behaviour.   
 
Most participants were female, which again reflects the gender spread of individuals who 
self-harm (NICE, 2004). However, differences in the severity or possible physical 
consequences of self-harm for the individuals in this study may exist, as participants were 
ultimately admitted to hospital for further medical treatment or observation.  Finally, 
research suggests that individuals who self-harm experience higher levels of depressed 
mood, anxiety, somatic complaints, anger and hostility than those who do not self-harm, 
(Guertin, Lloyd-Richardson, Spirito, Donaldson & Boergers, 2001), which was upheld in 
the present study.   
 
4.3 Contextualising the Results 
A number of practical explanations for negative staff attitudes towards patients presenting 
with self-harm have been identified in the literature, including a shift in caring expectations 
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for emergency medical staff (e.g. Johnston & Cowman, 2008), limited resources in 
emergency care settings (e.g. Hopkins, 2002), and a higher rate of return visits to A&E 
departments for patients who self-harm compared to other patients (Colman et al., 2004).  
Moreover, some authors (e.g. Scanlon & Adlam, 2009) suggest that professional attitudes 
reflect those prevalent in society, which are often judgemental and harmful, and are based 
on attributions of individual blame and intent to these acts.  Although caution should be 
used when considering the positive associations identified between perceived stigma and 
aspects of psychological distress in the self-harm group due to the small amount of data 
available for analysis, the correlations are statistically significant.  As such, it may be that 
research which emphasises the role of staff attitudes towards self-harm are too simplistic 
in explaining the negative perceptions of healthcare experiences for patients who self-
harm.  This is particularly pertinent given the identified correlation between perceived 
stigma and SCL-90-R Depression and Phobic Anxiety in the control group.   
 
While the control participants did not report the same elevated levels of perceived stigma 
and significantly differed in aspects of psychological distress – specifically, SCL-90-R 
Interpersonal Sensitivity, Depression, Paranoid Ideation and Psychoticism – compared to 
the self-harm group, the identified correlations with Depression and Phobic Anxiety 
suggest that their perceptions of treatment in hospital were related to aspects of current 
mood state.  This correlation between perceived hospital treatment and mood appears to 
represent a tendency for many hospital patients to interpret their healthcare experiences 
in a way that is congruent with their current mood state, regardless of their presenting 
problem.  When considering the associations between perceived stigma and SCL-90-R 
Depression and Interpersonal Sensitivity for the self-harm group, the possible influence of 
mood state is also apparent, with stronger associations between perceived stigma and 
SCL-90-R Depression and Interpersonal Sensitivity being identified.  Given the reported 
differences between the two groups in relation to current psychological distress, it seems 
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that this same pattern was amplified in the self-harm group in the context of their 
increased mood problems.   
 
The association between mood state and self-reported perceived stigma can be partially 
explained by experimental research which has identified memory impairments in 
individuals with depressed mood (e.g. Burt, Zembar & Niederehe, 1995).  In particular, a 
mood-congruent bias towards increased recognition and recall of negative-valenced or 
depression-related stimuli has been reported (Bower, 1981). Moritz, Glascher and 
Brassen (2005) compared the recognition and recall of depression-relevant words in 
depressed individuals with non-depressed controls, and noted that depressed individuals 
showed more bias towards emotionally charged words than neutral words.  These authors 
attempted to elucidate the presence of false memories in those with depression, and 
reported an elevated production of pseudo-memories.  They concluded that the responses 
of those in the depressed group were distorted in comparison with the control participants.  
Although the two groups of participants in the present study differed in terms of the 
severity of self-reported psychological distress, it may be that those in the control group 
differed in their mood state to the non depressed control participants in the Moritz et al. 
(2005) study who were recruited from the general population.  Given that the control 
participants in the present study were recruited from hospital settings, it seems 
reasonable to suggest that their current emotional state may have been influenced by 
their physical health concerns and subsequent acute admission to hospital. As such, they 
may have shown a similar pattern of memory bias to depressed individuals, which may 
have impacted upon their responses on the perceived stigma questionnaire.  Furthermore, 
the greater strength of the association between psychological distress and perceived 
stigma identified in the self-harm group may be the result of the correlation between 
severity of mood problem and extent of memory impairment identified by Bornstein, Baker 
and Douglass (1991).  In addition to the presence of this possible memory bias in both 
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groups of participants, the elevated perceptions of stigma identified in the self-harm group 
may be partially explained by differences relating to more stable constructs than current 
mood state, such as the presence of maladaptive schemata in individuals who self-harm. 
Schemata are broad, pervasive themes relating to the self and relationships with others, 
and are considered to influence an individual’s perceptions, interpretations, emotions and 
behaviours (Young, 1994).  Castille et al. (2007) recently reported that individuals who 
self-harm differ from non self-harming controls on schema domains of Social 
Isolation/Alienation, as well as Insufficient Self-Control/Self-Discipline.  This Social 
Isolation/Alienation schema relates to feeling isolated from the rest of the world, different 
from others and not part of any community.  It is therefore possible that the presence and 
prevalence of this schema also influenced the perceptions and interpretations of the 
healthcare experiences reported by those in the self-harm group.  
 
Alternatively, when considering self-harm in the context of early attachment relationships, 
Grocutt (2009) advises that self-harm serves both intrapersonal and interpersonal 
functions, soothing or punishing the individual at times of distress, and initiating 
interpersonal interactions.  Given the problematic early experiences often found in those 
who self-harm – and the early maladaptive schemata which may develop from them – 
these interpersonal interactions often re-create early attachment experiences and invite 
negative responses from others.  Furthermore, Motz (2001) suggests that the response of 
care-givers in relation to self-harming behaviour often reflects the fear and desperation of 
the individuals themselves, as well as the hostile and aggressive intentions behind this 
behaviour.  As such, healthcare systems often mirror the mind of the person who has self-
harmed by alternating between caring and punitive responses, which may be those 
perceived by patients who self-harm.  When considered the greater severity of 
psychological distress identified in the self-harm group, it may be that their perceived 
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negative experiences, particularly in relation to their interactions with staff, reflected their 
current psychological state.   
 
4.4 Clinical Implications of Results 
McAllister et al. (2002) suggested that negative responses to self-harm from staff serve to 
further reduce the self-esteem of these individuals which, as one of the most frequent 
reasons cited for self-harm is a means to regulate problematic emotions, may perpetuate 
this type of behaviour.  Since individuals who self-harm often seek out medical attention, 
reducing negative reactions towards self-harm may be an important first step for 
intervening with this behaviour.  This is particularly relevant in light of the assertion by 
Roa, Pillay, Abraham and Luty (2009) that accessing healthcare services is one of the 
most appropriate pathways for stigmatised individuals to integrate into society.   
 
One way in which this could be undertaken is to reduce the misunderstandings which 
exist about self-harm through the provision of training to medical staff working in general 
hospital settings.  Indeed, NICE Guidelines (2004) recommend that appropriate training is 
provided to all staff coming into contact with individuals who self-harm, in order to improve 
clinical practice and with the aim of reducing or preventing further self-harming behaviour.  
Since Peris et al. (2008) identified that additional mental health training and increased 
contact with individuals with mental health problems reduced biases in clinical decision-
making and improved positive responses from healthcare staff, it seems reasonable to 
suggest that providing training about self-harm could also reduce stigma towards and 
improve interactions with patients who present with this type of behaviour. 
 
4.5 Limitations of the Study  
The results presented should be viewed with some caution in light of the small number of 
participants in each group, which were substantially less than required by the power and 
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sample size calculations.  Despite this limitation, it is notable that strong and significant 
correlations were found between the critical variables of interest.  A further limitation was 
the uncorroborated self-report data for both groups that the study relied upon with respect 
to past medical history.  Moreover, while the provision of A&E services in Glasgow is 
based on the availability of hospital beds rather than specific locality or catchment area, 
limiting recruitment for the study to one research site may have reduced the likelihood of 
obtaining a representative sample of self-harming patients in Glasgow.   
 
When considering participants in the self-harm group, many individuals who were 
admitted to the emergency receiving ward did not meet the inclusion criteria of being able 
to consent to the study due to their current physical or psychological state.  It is therefore 
possible that the responses of participants may reflect only a subset of self-harming 
individuals presenting to the research setting.  Since these participants were admitted to 
hospital for further treatment, different data may have been collected from self-harming 
patients who were not admitted for further treatment.  While it could be argued that the 
results from the study apply only to those who self-poison as a form of self-harm, it should 
be noted that clinical guidelines for healthcare experiences for those who self-harm 
(NICE, 2004) make no distinction between those who self-poison and those who engage 
in other types of self-injury. 
 
There may, however, be important differences in the suicidal intent of the participants.  
Research has indicated that those who self-harm with suicidal intent differ in antecedent 
causes and outcome expectancies than those who undertake this behaviour without 
suicidal intent (Mangnall, 2008).  Including suicidal intent as a co-variate in this study may 
thus have led to increased understanding of the clinical characteristics of this sample and 
the applicability of these results.   
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4.6 Areas for Future Research 
Further research on the identified association between perceived stigma and aspects of 
psychological distress could be undertaken using larger samples than in this study, for 
both self-harming patients and patients with other presenting problems.  Exploring the 
influence of current psychological state on perceptions of treatment in hospital could have 
implications for improving the healthcare experiences of patients in these settings, 
whether presenting with self-harm or otherwise.  Increased understanding of the clinical 
characteristics of those who self-harm and the possible impact of these characteristics on 
perceptions of hospital experiences may identify areas for psychological intervention.  For 
example, interventions could be developed which aim to improve pervasive negative 
interpretations of interactions with others which may influence their perception of stigma.  
Moreover, as one of the recommendations from NICE (2004) is for staff training to 
improve healthcare experiences for those attending hospital for self-harm, future research 
could focus on the impact of such training on patients’ perceptions of stigma; this would 
also allow further elucidation of the role of staff attitudes and behaviour on perceived 
stigma in healthcare settings.   
 
5.  Conclusions 
Despite a number of methodological limitations to this study, particularly in relation to the 
small sample size and representativeness of the sample recruited, the results suggest that 
individuals who self-harm report higher levels of perceived stigma in general hospital 
settings in comparison with patients presenting with other types of injury.  Furthermore, 
the differences in perceived stigma appear to relate to elevated levels of psychological 
distress.  While this study has identified a number of possible explanations for this 
association, it is difficult to ascertain whether the elevated perceptions of stigma reported 
are the result of systemic staff responses to self-harm behaviour in healthcare settings, or 
a function of the individual’s current psychological state, or are the consequence of the 
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interaction of both.  Further research could be undertaken to test some of these 
hypotheses in order to help clarify this relationship between current mood state and 
perceived stigma in hospital settings. 
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Table 2.1 Demographic Characteristics of Participants  
 
 All Participants 
 (N = 20) 
Self-Harm Group 
(N = 10) 
Control Group 
(N = 10) 
Mann-
Whitney U 
p 
Gender Female = 16, Male = 4 Female = 8, Male = 2 Female = 8, Male = 2 N/A N/A 
Age Mean  = 43.5, SD = 11.40 Mean = 40.6, SD = 11.28 Mean = 46.4, SD = 11.32 36.50 0.315 
Years in Education Mean = 12, SD = 1.81 Mean = 12.6, SD = 1.78 Mean = 11.4, SD = 1.71 26.00 0.075 
Ethnicity White Scottish = 20 White Scottish = 10 White Scottish = 10 N/A N/A 
Employment 
Status 
Unemployed = 11 
Employed = 7 
Retired = 2 
Unemployed = 6 
Employed = 4 
Retired = 0 
Unemployed = 5 
Employed = 3 
Retired = 2 
N/A N/A 
SOC2000 
Classification 
Intermediate, non-manual = 4 
Semi-skilled manual = 2 
Personal services worker = 1 
Intermediate, non-manual = 3 
Semi-skilled manual = 1 
Personal services worker = 0 
Intermediate, non-manual = 1 
Semi-skilled manual = 1 
Personal services worker = 1 
N/A N/A 
Socio-Economic 
Class 
S-E Class 2 = 4 
S-E Class 4 = 3 
Unknown = 13 
S-E Class 2 = 3 
S-E Class 4 = 1 
Unknown = 6 
S-E Class 2 = 1 
S-E Class 4 = 2 
Unknown = 7 
N/A N/A 
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Table 2.2 Additional Participant Information 
 
 Self-Harm Group 
(N = 10) 
Control Group 
(N = 10) 
Reason for Attending 
Hospital/ Method of Self-Harm 
Overdose = 9 
Attempted drowning = 1 
Chest pains = 6 
Mini-stroke = 1 
Alcohol-related problems = 1 
Kidney problems = 1 
Liver problems = 1 
 
Injury while Intoxicated Yes = 7 
No = 3 
 
Yes = 1 
No = 9 
Previous Attendance at 
Hospital for Self-Harm 
Yes = 8 
No = 2 
 
N/A 
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Table 2.3 Clinical Characteristics of Participants 
Measure Self-Harm Group 
(N = 10) 
Control Group 
(N = 10) 
Mann-
Whitney U 
p 
SCL-90-R Somatisation Median = 63, Range = 17 Median = 64, Range = 51 44.00 0.684 
SCL-90-R Obsessive-Compulsive Median = 62.5, Range = 23 Median = 43, Range = 54 28.00 0.105 
SCL-90-R Interpersonal Sensitivity Median = 59.5, Range = 30 Median = 40, Range = 41 17.50 0.011* 
SCL-90-R Depression Median = 62.5, Range = 26 Median = 47.5, Range = 50 24.50 0.052* 
SCL-90-R Anxiety Median = 62, Range = 24 Median = 52.5, Range = 54 33.50 0.218 
SCL-90-R Hostility Median = 63.5, Range = 25 Median = 43.5, Range = 38 24.50 0.052* 
SCL-90-R Phobic Anxiety Median = 66.5, Range = 39 Median = 54.5, Range = 41 36.00 0.315 
SCL-90-R Paranoid Ideation Median = 59.5, Range = 22 Median = 40, Range = 48 21.00 0.029* 
SCL-90-R Psychoticism Median = 63, Range = 29 Median = 43.5, Range = 45 23.00 0.043* 
SCL-90-R GSI Median = 70, Range = 22 Median = 47, Range = 62 29.50 0.123 
SCL-90-R PST Median = 68, Range = 30 Median = 58.5, Range = 39 38.50 0.393 
SCL-90-R PSDI Median = 64, Range = 26 Median = 58.5, Range = 39 40.00 0.481 
Perceived Stigma Median = 49, Range = 96 Median = 15.5, Range = 58 16.00 0.009* 
*Significant at one-tailed, 0.05 level 
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Table 2.4 Correlations between SCL-90-R and Perceived Stigma – Self-Harm Group 
 
Perceived Stigma SCL-90-R 
Somatisation 
SCL-90-R 
Obsessive-
Compulsive 
SCL-90-R 
Interpersonal 
Sensitivity 
SCL-90-R 
Depression 
SCL-90-R 
Anxiety 
Spearman’s Correlation ρ 
 
Significance (One-tailed) 
-0.067 
 
0.427 
-0.079 
 
0.414 
0.685 
 
0.014 
0.723 
 
0.009 
0.293 
 
0.206 
 
 
Perceived Stigma SCL-90-R 
Hostility 
SCL-90-R 
Phobic Anxiety 
SCL-90-R 
Paranoid Ideation 
SCL-90-R 
Psychoticism 
SCL-90-R 
Global Severity 
Index (GSI) 
Spearman’s Correlation ρ 
 
Significance (One-tailed) 
-0.018 
 
0.480 
0.224 
 
0.267 
0.407 
 
0.121 
0.480 
 
0.080 
0.228 
 
0.265 
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Table 2.5 Correlations between SCL-90-R and Perceived Stigma – Control Group 
  
Perceived Stigma SCL-90-R 
Somatisation 
SCL-90-R 
Obsessive-
Compulsive 
SCL-90-R 
Interpersonal 
Sensitivity 
SCL-90-R 
Depression 
SCL-90-R 
Anxiety 
Spearman’s Correlation ρ 
 
Significance (One-tailed) 
0.256 
 
0.283 
0.460 
 
0.090 
0.338 
 
0.169 
0.596 
 
0.035 
0.401 
 
0.125 
 
 
 
 
Perceived Stigma SCL-90-R 
Hostility 
SCL-90-R 
Phobic Anxiety 
SCL-90-R 
Paranoid Ideation 
SCL-90-R 
Psychoticism 
SCL-90-R 
Global Severity 
Index (GSI) 
Spearman’s Correlation ρ 
 
Significance (One-tailed) 
0.329 
 
0.176 
0.595 
 
0.035 
0.336 
 
0.172 
0.497 
 
0.072 
0.396 
 
0.129 
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Abstract  
 
This reflective account focuses on some of my experiences relating to clinical practice 
whilst on placement within a Community Mental Health Team (CMHT), giving particular 
consideration to the role of the supervisory relationship and interactions with other team 
members in shaping these experiences.  By using Gibbs’ Model of Reflection (1998) to 
structure my thinking and identifying some relevant literature on the developmental aspect 
of supervision, I attempt to highlight the ways in which my personal experiences are likely 
to reflect typical professional development at this stage in my training.  I also consider how 
these placement experiences may assist me in making the successful transition to an 
independent practitioner when qualified, and draw parallels between the processes 
involved in clinical supervision and working therapeutically with clients.  Finally, I reflect on 
the usefulness of writing this account as a source of internal supervision. 
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Abstract 
In this reflective account I explore issues relating to the management of psychological 
systems, services and resources as specified by the Generic Key Role 6 of the National 
Occupational Standards for Psychology (British Psychological Society, 2002).  Using 
Borton’s Developmental Framework for Guiding Reflective Activities (1970), I draw mainly 
from my final year training experiences in a mainstream adult mental health service and 
specialist trauma service in order to understand the differences between a psychology-led 
and non-psychology-led service, as well as considering the influence of professional 
background on the way in which services develop and function. 
 
I outline some of the practical applications of my research training in terms of improving 
ways to deliver services, and examine possible changes to my future practice in relation to 
my experiences of working in various services.  I also discuss how some of my views on 
the nature of clinical psychology have evolved over the course of my training.  Finally, I 
suggest that my training experiences of entering into new services, and thinking about the 
ways in which the service is delivered, indicates that I am beginning to broaden my 
understanding of what management within clinical psychology actually entails, and 
developing the role I may have in shaping the service at a personal level. 
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Appendix 1.1 Instructions for Authors for Submission to Addiction  
 
Published since 1884 by the Society for the Study of Addiction to Alcohol and other Drugs 
Instructions for Authors 
1. GENERAL 
Addiction is a monthly international journal read in over 60 countries and has been in continuous 
publication since the Society for the Study of Addiction was founded in 1884. 
It welcomes unsolicited research reports, reviews, and letters relating to clinical, epidemiological, human 
experimental, policy-related and historical aspects of any behaviours that have addictive potential 
including, but not limited to, use of alcohol, opiates, stimulants, cannabis, tobacco, as well as gambling. 
The acceptance rate is currently about 20%. Research reports should present original findings and 
normally be limited to 3500 words excluding abstract, tables and references. There is no minimum 
length. Reviews should normally be 'systematic' (i.e. adopt standard systematic review procedures) and 
be no longer than 4000 words for the main text. Letters should normally be no more than 500 words. 
We are willing to make exceptions to word length stipulations in rare cases but otherwise we encourage 
authors to make use of a facility we offer for supplementary material to be stored with the online version 
of the article. 
To submit an article to Addiction please go to http://mc.manuscriptcentral.com/addiction. We aim 
to get a response to authors within 12 weeks. 
Authors must not submit articles that have been published elsewhere or are under consideration for 
publication elsewhere. 
Addiction also publishes invited editorials, articles 'for debate', commentaries on articles, interviews with 
leading figures in the field, and book reviews. 
Authors who are interested in contributing one of the invited types of article may make a proposal to the 
commissioning editor (Peter Miller via molly@addictionjournal.org). 
Authors submitting manuscripts intended for one of our series (e.g. Global Diversion of Pharmaceutical 
Drugs, Policy Case Studies, Vested Interests) should in the first instance contact the Commissioning 
Editor via molly@addictionjournal.org for a concept review. If invited to submit, please choose 
"Series" as the Manuscript Type, and be sure to select "Europe, Africa & Asia" as the Regional Office. 
For a list of article types with definitions and word limits please click here: 
http://www.blackwellpublishing.com/pdf/add_definitions.pdf. 
2. REQUIREMENTS FOR SUBMITTED ARTICLES 
For information on how to write articles for Addiction, authors should look at recent articles of the type 
they are proposing to submit. They should pay special attention to the following: 
 Research report and review manuscripts must have the following parts in this order: front sheet 
including title, list of authors, affiliations and addresses, running head, word count,* conflict of interest 
declaration (see below), clinical trial registration details (if applicable); abstract, introduction, methods, 
results, discussion, acknowledgements, references, figures and tables with legends. Do not insert tables 
and figures into the main body of the text. Please key them in the text but place them at the end of the 
document. 
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 *A word count is required for the main body of the text only, ie. excluding abstract, references, 
tables, figures etc. 
 Addiction will publish occasional monographs of up to 10,000 words including references. 
Monographs should be major pieces of writing. The kinds of papers that would qualify might be extensive 
systematic reviews of a major topic or a series of linked studies addressing a common research question. 
For full description please view our definition of all article types linked above. 
 Abstracts must be structured using the following headings: Aims, Design, Setting, Participants, 
Measurements, Findings, Conclusions. For Review articles please use: Aims, Methods, Results, 
Conclusions. Abstracts should generally be no more than 250 words. Any numbers provided in the 
abstract must match exactly those given in the main body of the text or tables. The conclusion must be 
written in such a way as to make clear what is the main generalisable statement resulting from the 
study; i.e. the sentence(s) that someone citing the study might use to describe the findings. 
 References should follow the basic numbered Vancouver style. Provide up to the first six authors 
and then follow by et al. Issue/part numbers are not required. Do not include citations to sources such as 
conference abstracts or unpublished work. 
 Authors should cite exact p values for primary statistical tests. Addiction adopts the conventional 
5% value for statistical significance and does not accept terms such as 'trend' for cases where p0.10. 
 Authors are required to archive any web references before citing them using WebCite ® technology 
(http://www.webcitation.org). This is an entirely free service that ensures that cited webmaterial will 
remain available to readers in the future. 
 Randomised controlled trials should be reported using the CONSORT guidelines available at 
www.consort-statement.org, and authors should include with their manuscript a completed checklist 
and flow diagram in accordance with the guidelines. 
 We expect authors who wish to communicate results from cohort, case-control, cross-sectional, 
non-randomised evaluations, or systematic reviews and meta-analyses to review guidelines concerning 
their analysis and reporting. The Reporting of Observational studies in Epidemiology (STROBE; 
http://www.strobe-statement.org), the Transparent Reporting of Evaluations with Nonrandomized 
Designs (TREND; http://www.cdc.gov/trendstatement), or the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA; http://www.prisma-statement.org/) should be consulted. A 
completed checklist and flow diagram should be included as an appendix to the submitted manuscript 
following the appropriate guideline. 
 Prevalence surveys - Addiction welcomes such studies but does not publish surveys that primarily 
focus on description of a phenomenon that is known to be common worldwide (or common in the drug 
sense, e.g. heroin use), that is to say, prevalence which is already known to a large degree. Studies that 
document the start of a new 'epidemic' of a particular drug use might be considered, but largely 
descriptive data on the prevalence of this or that drug use in this or that place is largely excluded. Not 
excluded would be surveys that use a cross-sectional study to describe an association with this or that 
risk factor where that association is not well established. 
 Addiction normally requires that clinical trials are registered in a publicly accessible database. The 
name of the trial register and the clinical trial registration number on the front page of the manuscript. A 
full list of registers can be found via the WHO International Clinical Trials Registry Platform (ICTRP) 
http://www.who.int/ictrp/en/. 
 Evaluations involving behavioural interventions must include full manuals or protocols, or at least 
very detailed descriptions, of those interventions as supplementary files to be included as supplementary 
material published with the online version of the article. 
 If English is not the first language of authors, they are advised to have their manuscript edited by a 
native English speaker before submission. However, we will do our best to accommodate papers from 
authors in countries where the resources do not exist for this. 
A manuscript that does not comply with journal requirements will be unsubmitted and returned to the 
author centre. A useful guide to writing up papers for journals such as Addiction can be found in West R 
(2000) A checklist for writing up research reports. Addiction, 95, 1759-61. 
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Appendix 1.2 Quality Assessment Tool 
Objectives and Study Type Quality Rating 
1. Aims/ questions/ hypotheses clearly stated or described 2  Adequate                    
1  Partial 
0  Inadequate            
 
2.  Study Type 
 
 
 
2 Randomised control trial 
1 Non-randomised control trial 
0 Uncontrolled trial 
Sampling Quality Rating 
3.  Sample Type 
 
 
2  Geographic cohort 
1  Convenience sample 
0  Highly selective 
 
4.  Baseline demographics and clinical characteristics of 
groups clearly stated to allow comparisons 
 
 
2  Adequate                    
1  Partial 
0  Inadequate 
5.  Inclusion and exclusion criteria stated and used for both 
groups, where appropriate 
 
 
2  Adequate                   
1  Partial 
0  Inadequate 
6.  Sample size adequate (i.e. 27 in each group) or based on 
power calculation 
 
 
2  Adequate                    
1  Partial 
0  Inadequate 
7.  Well-matched control group used or, if no control group, 
attempts to control for confounding variables in design 
 
 
2  Adequate                    
1  Partial 
0  Inadequate 
8.  Diagnostic criteria for PTSD and co-morbid substance 
misuse used, e.g. DSM-IV or ICD-10 
 
 
2  Adequate                    
1  Partial 
0  Inadequate 
Allocation  Quality Rating 
9.  Process of allocation to groups adequately described 
 
 
 
 
2  Adequate                    
1  Partial 
0  Inadequate 
Not applicable to study  
10.  Allocation carried out independently of trial research 
team 
 
 
 
2  Adequate                    
1  Partial 
0  Inadequate 
Not applicable to study           
Assessment of Outcomes Quality Rating 
11.  Assessment carried out independently of therapists 
 
 
 
 
2  Adequate                    
1  Partial 
0  Inadequate 
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12.  Standardised measures applied and validated for PTSD 
(i.e. reliability and validity data specified) 
 
 
2  Adequate                    
1  Partial 
0  Inadequate 
13.  Standardised measures applied and validated for 
substance misuse (i.e. reliability and validity data specified) 
 
 
2  Adequate                    
1  Partial 
0  Inadequate 
Intervention Quality Rating 
14.  Intervention adequately described or intervention 
protocol used 
 
 
2  Adequate                    
1  Partial 
0  Inadequate 
15.  Adherence to intervention protocol or intervention quality 
assessed  
 
 
2  Adequate                    
1  Partial 
0  Inadequate 
Analysis Quality Rating 
16.  Data analysis appropriate to study design and type of 
outcome measure 
 
 
2  Adequate                    
1  Partial 
0  Inadequate 
17.  Intention to treat analysis used (i.e. analysis includes all 
participants allocated to intervention) 
 
 
2  Adequate                    
1  Partial 
0  Inadequate 
18.  Attrition rates specified 
 
 
 
2  Adequate                    
1  Partial 
0  Inadequate 
19.  Results clearly stated and relate to research aims/ 
hypotheses 
 
 
2  Adequate                    
1  Partial 
0  Inadequate 
20.  Confidence intervals, effect sizes, p-values etc. provided 
where appropriate 
 
 
2  Adequate                    
1  Partial 
0  Inadequate 
Discussion Quality Rating 
21.  Recommendations for clinical practice/ future research 
identified from results 
 
 
2  Adequate                    
1  Partial 
0  Inadequate 
22.  Limitations of study clearly identified 
 
 
 
2  Adequate                    
1  Partial 
0  Inadequate 
Quality Assessment Rating Key:        
 
Excellent = >75%  Total score =    __________ / 44         
Good = >60%   Percentage =    __________ % 
Fair = >50%   Quality Rating Descriptor =  __________ 
Poor = <49% 
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Appendix 2.1 Instructions for Submission to British Journal of Clinical Psychology 
British Journal of Clinical Psychology (BJCP) - Notes for 
Contributors 
The British Journal of Clinical Psychology publishes original contributions to scientific 
knowledge in clinical psychology. This includes descriptive comparisons, as well as studies of 
the assessment, aetiology and treatment of people with a wide range of psychological problems 
in all age groups and settings. The level of analysis of studies ranges from biological influences 
on individual behaviour through to studies of psychological interventions and treatments on 
individuals, dyads, families and groups, to investigations of the relationships between explicitly 
social and psychological levels of analysis. 
The following types of paper are invited: 
 Papers reporting original empirical investigations  
 Theoretical papers, provided that these are sufficiently related to the empirical data  
 Review articles which need not be exhaustive but which should give an 
interpretation of the state of the research in a given field and, where appropriate, 
identify its clinical implications  
 Brief reports and comments  
1. Circulation 
The circulation of the Journal is worldwide. Papers are invited and encouraged from authors 
throughout the world. 
2. Length 
Papers should normally be no more than 5000 words (excluding abstract, reference list, tables 
and figures), although the Editor retains discretion to publish papers beyond this length in cases 
where the clear and concise expression of the scientific content requires greater length.  
3. Submission and reviewing 
All manuscripts must be submitted via our online peer review system. The Journal operates a 
policy of anonymous peer review.  
4. Manuscript requirements 
 Contributions must be typed in double spacing with wide margins. All sheets must 
be numbered.  
 Tables should be typed in double spacing, each on a separate page with a self-
explanatory title. Tables should be comprehensible without reference to the text. 
They should be placed at the end of the manuscript with their approximate 
locations indicated in the text.  
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 Figures can be included at the end of the document or attached as separate files, 
carefully labelled in initial capital/lower case lettering with symbols in a form 
consistent with text use. Unnecessary background patterns, lines and shading 
should be avoided. Captions should be listed on a separate sheet. The resolution of 
digital images must be at least 300 dpi.  
 For articles containing original scientific research, a structured abstract of up to 250 
words should be included with the headings: Objectives, Design, Methods, Results, 
Conclusions. Review articles should use these headings: Purpose, Methods, 
Results, Conclusions. Please see the document below for further details: 
British Journal of Clinical Psychology - Structured Abstracts Information  
 For reference citations, please use APA style. Particular care should be taken to 
ensure that references are accurate and complete. Give all journal titles in full.  
 SI units must be used for all measurements, rounded off to practical values if 
appropriate, with the imperial equivalent in parentheses.  
 In normal circumstances, effect size should be incorporated.  
 Authors are requested to avoid the use of sexist language.  
 Authors are responsible for acquiring written permission to publish lengthy 
quotations, illustrations, etc. for which they do not own copyright.  
For guidelines on editorial style, please consult the APA Publication Manual published by the 
American Psychological Association. 
5. Brief reports and comments 
These allow publication of research studies and theoretical, critical or review comments with an 
essential contribution to make. They should be limited to 2000 words, including references. The 
abstract should not exceed 120 words and should be structured under these headings: Objective, 
Method, Results, Conclusions. There should be no more than one table or figure, which should 
only be included if it conveys information more efficiently than the text. Title, author name and 
address are not included in the word limit. 
6. Publication ethics 
All submissions should follow the ethical submission guidelines outlined the the documents 
below: 
Ethical Publishing Principles – A Guideline for Authors  
Code of Ethics and Conduct (2006)  
7. Supplementary data  
Supplementary data too extensive for publication may be deposited with the British Library 
Document Supply Centre. Such material includes numerical data, computer programs, fuller 
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details of case studies and experimental techniques. The material should be submitted to the 
Editor together with the article, for simultaneous refereeing. 
8. Copyright 
On acceptance of a paper submitted to a journal, authors will be requested to sign an 
appropriate assignment of copyright form. To find out more, please see our Copyright 
Information for Authors.  
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Appendix 2.2 Participant Information Sheet 
PARTICIPANT INFORMATION 
 
You are invited to take part in a research study being undertaken in hospitals throughout 
Glasgow. Please read the following information before deciding whether to participate in 
the study.   
Reasons for the Study 
This study aims to investigate the experiences of hospital patients throughout the city.  
Previous research suggests that patients receive different care in hospital depending on 
why they were admitted. This is particularly noticeable when comparing people who have 
been injured accidentally with people who have harmed themselves.   
This study is being undertaken as part of a Doctorate Degree in Clinical Psychology for 
the Lead Researcher, Valerie McKenna (NHS Greater Glasgow & Clyde and University of 
Glasgow). 
What does the study involve? 
If you decide to take part in the study, you will be asked to complete a Consent Form with 
a member of the research team. You will then be given a questionnaire pack to complete 
in private and seal in the envelope provided.  You can then return this envelope to the 
person who gave you the questionnaires or put it in the box marked “Research” on the 
ward. Your envelope will only be opened by a member of the research team. 
The pack will contain 3 questionnaires asking about: 
 Your background information (such as age, gender and ethnicity) and  the reason 
why you attended A&E  
 Your current mental health and well-being 
 Your perceptions of the service you received in hospital 
  
Completing these questionnaires will take around 30 minutes of your time and you will 
only have to do this on one occasion.   
What are my rights? 
Even if you agree to take part in the study, you are free to withdraw from the study at any 
time and without having to give a reason. If you choose not to participate or decide to 
withdraw your consent, this will not affect your right to the standard practice of healthcare 
provided in the ward.    
If you agree to participate in the study, your involvement is voluntary (you are free to 
withdraw at any time) and confidential. 
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What will happen to the information collected in the study? 
All information collected will be treated confidentially and any information which could 
identify you as a participant will be removed in any research reports.  All records will be 
stored in accordance with the Data Protection Act and held in a secure data storage 
system which is protected by passwords. 
 
If you have any questions about this study please contact: 
 
Valerie McKenna 
Trainee Clinical Psychologist 
Department of Psychological Medicine 
Gartnavel Royal Hospital 
1055 Great Western Road 
Glasgow 
G12 0XH 
 
Email: Valerie.McKenna@ggc.scot.nhs.uk 
 
Thank you for taking the time to read this information. 
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Appendix 2.3 Participant Consent Form 
Participant ID:    
CONSENT FORM 
    
PLEASE CIRCLE YOUR RESPONSE 
 
Have you read and understood the Participant Information?  YES/ NO 
 
Have you been given an opportunity to ask questions about the study? YES/ NO 
  
Have you received enough information about this study?   YES/ NO 
 
Do you understand that your participation is entirely voluntary?  YES/ NO 
 
Do you understand that you are free to withdraw from this study?  YES/ NO 
  
 At any time?        YES/ NO 
 
 Without having to give a reason for withdrawing?   YES/ NO 
 
 Without this affecting your right to routine healthcare?  YES/ NO 
 
Do you agree to take part in this study?     YES/ NO 
 
 
Signature: ………………………………………………….. …….  Date: ………………… 
 
Name in capital letters: …………………………………………. 
 
Witnessed by:  …………………………………………………….   Date: ………………… 
 
 
If you would like feedback on the results of this study when it is complete, please  
add contact details where the feedback can be sent: 
 
I would like to receive feedback of the results of this study   YES/ NO  
 
I can be contacted at: 
 
Address:  ………………………………………………………….. 
        ………………………………………………………...... 
  ………………………………………………………….. 
 
OR Email: ………………………………………………………….. 
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Appendix 2.4 Demographic Questionnaire 
 
 Participant ID:    
BACKGROUND INFORMATION 
 
Please complete the following: 
 
1.  Age:         2. Gender:  Male           Female 
 
3.  Number of years in full-time education: …………………………………. 
 
4.  Ethnicity: 
A.  White 
I) Scottish  II) English  III) Welsh  IV) Irish  
V) Other    Please describe………………………………………… 
 
B. Asian, Asian Scottish, Asian Welsh or other Asian British 
I) Indian  II) Pakistani  III) Bangladeshi IV) Chinese  
V) Other    Please describe………………………………………… 
 
C.  Black, Black Scottish, Black English, Black Welsh, or other Black British 
I) African  II) Caribbean  
III) Other    Please describe………………………………………… 
 
D. Mixed or other ethnic background 
I) Mixed   II) Other  Please describe………………………………………… 
 
5.  Current employment status: 
I) Unemployed II) Retired  
III) Employed    Job title …………………………………………………………. 
 
6A.  Reason for attending hospital:         
 
6B.  Did this injury occur while you were intoxicated?   
Yes           No 
 
If this injury was non-accidental (i.e. self injury), please complete Question 7A and 7B: 
 
7A.  Method of self injury:           
 
7 B. Have you attended hospital for self injury before? 
Yes         No 
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Appendix 2.5 Perceived Stigma Questionnaire 
 
Participant ID:    
 
Your Treatment in Hospital 
       
Please read the following 30 statements carefully and circle the response which most 
applies to your recent experiences during your current admission to hospital: 
 
1. Staff were helpful to me 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
2. My waiting times were the same as other patients’ waiting times  
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
3. My treatment was deliberately painful 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
4. Staff were disappointed in me 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
5. Staff were friendly towards me 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
6. Staff did not respect me 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
7. Staff treated me the same as other patients 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
8. Staff treated my injuries as genuine  
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
9. Staff were afraid of me 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
10. Staff made negative comments about me 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
 
Please turn over 
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11. Staff empathised with my injuries 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
12. Staff ignored me 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
13. Staff were not concerned about me 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
14. My treatment was as good as it could have been 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
15. Waiting times were longer for me 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
16. Staff did not hold me responsible for my injuries 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
17. Staff were frustrated by me 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
18. Staff did their best to help me 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
19. Staff were professional during my treatment 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
20. Staff were angry at me 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
21. Staff treated me more negatively than other patients 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
22. Staff treated me with respect 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
23. My treatment was as good as other patients’ treatment 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
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24. Staff did not comment on my injuries 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
25. My injuries were not treated as genuine 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
26. Staff were kind to me 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
27. Staff blamed me for my injuries 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
28. My treatment was worse than other patients’ treatment 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
29. Staff voiced disapproval about my injuries 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
 
30. Staff responded positively to me 
Strongly   Neither Agree    Strongly 
Disagree Disagree nor Disagree  Agree  Agree 
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Background:  Stigma research indicates that individuals with mental health problems 
report high levels of perceived stigma and differences in the quality of care they receive in 
general hospital settings.  Research has also identified negative staff attitudes towards 
patients who self-harm in general hospital settings.  No research to date has attempted to 
measure the perception of stigma in self-harm patients in general hospital settings in 
comparison to a control group of other hospital patients.   
 
Aims:  This project aims to examine perceived stigma in a sample of self-harm patients 
within general hospital settings by comparing their experiences to a control group of other 
hospital patients.   
 
Methods:  Participants will be 23 patients admitted to general hospital wards after 
presenting to Accident and Emergency (A&E) departments following an incident of self-
harm and 23 hospital controls.  These controls will be matched as closely as possible to 
the self-harming patients for age, gender and socio-economic status, and will be admitted 
to the same receiving wards for any other physical health problem or non-deliberate injury.  
Participants in each group will complete a purpose-designed measure of perceived 
stigma, as well as a measure of current psychological state (SCL-90-R) and a 
questionnaire containing demographic information, reason for admission and self-harm 
specific questions.   
 
Applications:  Should this study identify higher levels of perceived stigma in self-harm 
patients in comparison to hospital control patients, it may be appropriate for Liaison 
Psychiatry staff to undertake additional training with general hospital staff.  This may be of 
particular importance given the potentially negative impact of stigma on self-esteem, 
which could have a maintaining role in self-harming behaviour. 
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1.  Background   
1.1 Concept of Stigma 
Stigma has been defined as “an attribute that extensively discredits an individual, reducing 
him or her from a whole and usual person to a tainted or discredited one” (Goffman, 1963, 
p.3).  Markers of stigma may vary in visibility and controllability, and can influence 
appearance, group membership and behaviour (Major & O’Brien, 2005).  To illustrate, 
stigma has been identified in individuals with a number of physical health conditions which 
are considered to: cause behaviours perceived as unusual or frightening (including 
epilepsy and Tourette’s Syndrome); reflect personal inadequacy (such as drug 
dependence and obesity); result from perceived immoral behaviour (for example, HIV and 
AIDS); and impact on private or embarrassing body parts (such as, urological conditions 
and faecal incontinence) (West & Hardy, 2007).  Moreover, the experience of stigma has 
been examined in those with mental health problems, particularly in the context of 
healthcare settings, as there is considerable evidence that the physical health problems of 
those with mental health problems are frequently under-diagnosed and inappropriately 
treated (Kuey, 2008).   
 
1.2 Mental Health Stigma in Healthcare Settings 
While research indicates that mental health stigma does not present a significant  barrier 
to services (e.g. Golberstein, Eisenberg & Gollust, 2008; Cooper, Corrigan & Watson, 
2003), Roa, Pillay, Abraham & Luty (2009) note that mental health stigma in health 
services is particularly concerning, as these services represent one of the most 
appropriate pathways for people with mental health problems to integrate into society.  
Their study utilised a vignette methodology and identified stigmatising attitudes towards 
those with mental health problems in healthcare staff.  Additionally, Liggins and Hatcher 
(2005) explored stigmatising experiences of patients and staff in general hospital settings 
and identified a number of salient stigma themes relating to fear, hopelessness, labelling, 
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disbelief in illness and how the relationship between stigmatiser and stigmatised is 
communicated.  These researchers note these themes relate to mental health stigma 
within the general population and suggest that there is an additional perception that the 
patient is not genuinely ill in hospital settings.   
 
A recent study undertaken by Peris, Teachman and Nosek (2008) measured implicit and 
explicit biases towards people with mental health problems in individuals with different 
levels of mental health training and investigated the influence of stigma on clinical 
decision-making.  These authors hypothesised that a higher level of training in mental 
health and greater exposure to individuals with mental health problems would result in 
less implicit and explicit biases.  These hypotheses were upheld, with higher levels of 
training and increased contact with individuals with mental health problems resulting in 
more positive responses.  This study also used a vignette methodology to explore clinical 
decision making and reported that bias predicted clinical decision making, with explicit 
bias as a significant predictor of negative prognosis and implicit bias relating to over-
diagnosis.  These authors suggest that this finding is particularly significant when 
considering the role that negative attitudes may have on care provision, even among 
professionals with training in mental health.   
 
A comprehensive review on the role of nursing staff in mental health stigma (Ross & 
Goldner, 2009) applied Schulze’s (2007) concept of healthcare staff occupying one of 
three positions: i) as stigmatiser of those with mental health problems, ii) as stigmatised 
by their association with and direct experience of mental health problems, and iii) as de-
stigmatiser or advocates for those with mental health problems.  When reviewing 
evidence for healthcare staff occupying the role of stigmatiser, these authors identify the 
presence of negative attitudes and themes of fear, blame and hostility as having a 
detrimental impact on the quality of care for these individuals.  While the theme of fear 
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partially relates to stereotypes within the general population, the authors suggested it 
could also be explained by staff feeling deskilled and ill-equipped to manage and support 
these individuals.  They suggested that blame relates to misattributing mental health 
problems to personal characteristics, while hostility arises from the belief that these 
patients are squandering healthcare resources which could be better utilised.  These 
authors noted a general devaluing of psychiatric services, which they suggested places 
some staff in the second role of stigmatised by their association to these services, in 
addition to their personal mental health experiences.  They concluded that nursing staff 
have a valuable role in the third position of de-stigmatiser of mental health problems.  
 
1.3 Understanding Self-Harm 
Self-harm has been defined as “any act which involves deliberately inflicting pain and/or 
injury to one’s own body, but without any suicidal intent; it is usually an attempt to stay 
alive in the face of great emotional pain” (Arnold & Magill, 2001).  While self-harm has 
traditionally been understood in the context of an on-going mental health problem or 
viewed as an attempt at suicide, research increasingly suggests that this is not the case.  
For example, O’Connor, Rasmussen, Miles and Hawton (2009) undertook a recent survey 
of self-harm in adolescents in Scotland and reported that the prevalence of self-harm in 
this population is similar to that of England, despite Scotland having a suicide rate twice 
as high as England.  Research does, however, indicate significant differences between 
those who self-harm and those who do not on self-reported measures of psychological 
distress, such as the SCL-90-R (Sarno, Madeddu and Gratz, 2009).   
 
A further study, Rasmussen et al. (in press), has examined the Cry of Pain Model of Self-
Injury (Williams, 2001) which conceptualises self-harm as a behavioural response to a 
feeling of being trapped in a stressful situation which fulfils three criteria: the presence of 
defeat, no potential for escape and no potential for rescue.  Within this model, a mediating 
  
 
 
111 
 
relationship exists between a sense of entrapment and the defeat-suicide ideation 
relationship, and rescue factors, such as positive future thinking, have a moderating role 
in the entrapment-suicidal ideation relationship.  These researchers identified differences 
in anxiety, depression and suicidal ideation between the three groups, providing some 
empirical support for this Cry of Pain Model of Self-Injury.  Despite this increased 
understanding of the purpose of self-harm, research indicates that misunderstandings 
about self-harm are pervasive in general hospital settings.  For example, Ross and 
Goldner (2009) suggest that there is an implicit belief that patients who self-harm do so 
from a specific volition to die and there is little understanding of the purpose and function 
of self-injury.  
 
1.4 Healthcare Experiences of Self-Harming Patients 
While NICE Guidelines (2004) for the short-term physical and psychological management 
and secondary prevention of self-harm recommend that all self-harm patients have the 
right to the same quality of care as all other patients, some researchers suggest that this 
is often not the case.  McAllister, Creedy, Moyle and Farrugia (2002) note that in A&E 
departments where cases are prioritised according to life threat, those who self-harm are 
frequently ignored and made to wait for long periods.  These authors also suggest that 
clients frequently recognise rejection during their contact with healthcare staff, which can 
lead to further self-harming behaviour.  In addition to objective differences in health care 
provision, a large body of research has identified negative attitudes to self-injury from 
healthcare staff.    
 
Friedman et al (2006) attempted to examine the factors which predict the attitudes of A&E 
staff to those who self-harm by cutting and reported that staff recognised self-harm as 
significant problem, but felt unskilled and under-resourced when dealing with it.  
Additionally, a large proportion of respondents (80%) conceptualised self-harm as 
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attention-seeking and manipulation, rather than individuals seeking appropriate medical 
attention.  They found high levels of staff frustration which did not relate to level of 
experience or training on self-injury.  Despite the belief that de-stigmatisation occurs 
through increased contact with the stigmatised other (e.g. Kuey, 2008), these researchers 
found that negative staff views persisted in spite of the large amount of contact that A&E 
staff have with those who self-injure by cutting.   
 
A recent audit, service evaluation and quality improvement initiative was undertaken by 
the Royal College of Psychiatrists in relation to their Quality Standards for Health Care 
Professionals for services for people who self-harm (Royal College of Psychiatrists, 2006).  
This comprehensive national programme again revealed that staff in general hospital 
settings feel unskilled and badly informed as to how to best support self-harming clients 
and that staff attitudes and behaviour are the best predictors of patients’ experiences of 
the care they receive (Blackwell & Palmer, 2008).  This programme also highlighted high 
variation in the quality of care provision for patients who self-injure.    
 
Overall, the literature suggests that staff responses to patients with mental health 
problems or who engage in self-harm behaviour differ from those who present to hospital 
settings with physical health problems or accidental injury.  While much of this research 
suggests that this difference relates, in part, to mental health stigma, no research to date 
has attempted to measure the existence of stigma towards patients who self-harm in 
hospital settings. 
 
2.  Aims and hypotheses 
2.1 Aims 
This project aims to extend pervious research on mental health stigma in healthcare 
settings and negative staff attitudes towards self-harm patients by measuring perceived 
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stigma of self-harm patients within general hospital settings and compare them with 
control group of other patients.  Participants in each group (i.e. self-harmers and hospital 
controls) will complete measures of perceived stigma and current psychological state, as 
well as a general questionnaire collecting demographic information, reason for admission 
(i.e. self-harm or other physical health concern) and self-harm specific questions.   
 
2.2 Hypotheses 
It is hypothesised that self-harmers will report greater perceptions of stigma than hospital 
control patients.  Additionally, it is hypothesised that greater perceptions of stigma will 
positively correlate to self-reported level of psychological distress, as measured by the 
SCL-90-R.  Finally, positive correlations are predicted between perceived stigma and the 
subscales of Paranoid Ideation and Interpersonal Sensitivity on the SCL-90-R.   
 
3.  Plan of Investigation 
3.1 Participants 
Participants will be patients who have been admitted to acute receiving wards after 
presenting to Accident and Emergency (A&E) departments at hospitals in Glasgow - 
Western Infirmary, Southern General, Victoria Infirmary and Royal Infirmary - following an 
episode of self-harm.  The provision of A&E services within Glasgow is based on the 
availability of hospital beds, rather than specific locality, so a representative sample of 
patients will be obtained from these four sites.  This project will utilise a control group of 
individuals who will be matched by gender, age and socio-economic status, as closely as 
possible, to those in the self-harm group and who have been admitted to the same acute 
receiving wards as the self-harm patients for any other physical health complaint or non-
deliberate injury.   
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3.2 Inclusion and Exclusion Criteria 
Participants will be included in the study if they are admitted to an acute receiving ward in 
one of the four hospital sites following an incident of self-harm or are a matched control 
with any other physical health problem or non-deliberate injury and consent to participate.  
Patients will be excluded from the study if they:  1) are unfit for interview due to their 
current physical or psychological state; 2) are unable to give informed consent; and 3) do 
not speak English as a first language.   
 
3.3 Recruitment Procedures 
Participants in the self-harm group will be assessed by members of the Glasgow Liaison 
Psychiatry Service, as per standard clinical practice, prior to being approached about 
participation in the study.  These assessments are undertaken in a general ward setting 
after patients have attended A&E and are used to identify appropriate follow-up care from 
the general ward setting.  Potential participants in both groups (i.e. self-harm and hospital 
controls) will be given a Participant Information Sheet detailing the study before being 
invited to take part and their informed consent obtained.  Both groups of participants will 
be recruited from the general receiving wards after attending A&E in each of the four sites 
identified.  Participants in the control group will be recruited once information about 
participants in the self-harm group has been collated to maximise appropriate matching. 
 
3.4 Measures 
3.4.1 Demographic Questionnaire  
Participants will complete a questionnaire which will collect standard demographic 
information (i.e. age, gender, ethnicity, employment status and level of education), reason 
for hospital admission (i.e. self-harm or other physical health complaint) and self-harm 
specific questions (e.g. previous history of self-harm and method of self-harm).  Socio-
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economic status will be identified using the Standard Occupational Classification 
(SOC2000) and level of education. 
 
3.4.2 Measure of Perceived Stigma  
As standardised measures of perceived mental health stigma (e.g. King et al, 2007), were 
unsuited to both groups of participants in the study, a purpose-designed measure based 
on current research evidence will be used.  This will be a Likert scale consisting of 30 
items focussing on three areas identified from published literature on mental health stigma 
and negative staff attitudes to self-injury, namely McAllister et al (2002).  These three 
areas are: 1) emotional responses of staff (for example, feelings of anger, fear and 
frustration towards patients); 2) objective experiences (such as increased waiting times 
and painful treatment), and 3) professional conduct of staff (including making negative 
comments and not treating injuries as being genuine).  The five items in each of these 
three areas (15 items in total) are counterbalanced by an equal number (15) of positive 
and neutral statements.  Participants will be asked to rate their recent experiences in 
general hospital wards on a five-point scale ranging from “Strongly Disagree” to “Strongly 
Agree,” with a scoring range of 0-120.   
 
Due to time constraints, this measure will not be assessed for reliability or validity.  
However, the measure was piloted on a group of ten members of the public for ease of 
understanding.   It is estimated that it will take up to ten minutes to complete.   
 
3.4.3 Measure of current psychological state:  Symptom Checklist-90-R (SCL-90-
R) (Derogatis, 1994)  
This tool is designed to measure a broad range of psychological problems and provide an 
overview of an individual’s current level of psychological distress and the intensity of self-
reported problems at a specific time point.   The SCL-90-R test contains 90 items and 
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evaluates nine dimensions:  Somatisation, Obsessive-Compulsive, Interpersonal 
Sensitivity, Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation and 
Psychoticism.  This measure has been appropriately normed for both groups in the study 
and can take up to 15 minutes to complete.  
 
3.4.4 Design 
This research will utilise a cross-sectional, matched control design. 
 
3.4.5 Research Procedures 
Participants will be recruited from the general receiving wards within the specified hospital 
sites through members of the Glasgow Liaison Psychiatry Service.  Potential participants 
in the self-harm group will be approached by nursing staff and/or the principal researcher 
once they have attended a routine risk assessment appointment with Glasgow Liaison 
Psychiatry Service staff, as per routine care provision.  They will be given a Participant 
Information Sheet at the end of this appointment and, if they agree to participate, they will 
complete a Consent Form with nursing staff and/or the principal researcher.  Control 
participants will be approached from the same acute receiving wards by the principal 
researcher following these same procedures.   
 
Both groups of participants will be given a questionnaire pack to be completed in private.  
They will then return the completed measures to the individual who administered them or 
place them in a box marked “Research” on the ward.  This process will be outlined in the 
Participant Information Sheet and in the instruction sheet included in the questionnaire 
pack.   
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3.4.6 Justification of sample size 
As the primary outcome measure proposed in this study has not been used in previous 
research, a power calculation was undertaken using data from research with people who 
self-harm on the SCL-90-R measure (Sarno, Madeddu & Gratz, 2009).  This research 
revealed differences on this measure between three groups of participants: 1) those who 
do not self-harm (No Self-Harm); 2) those who self-harm episodically (Episodic Self-
Harm); and 3) those self-harm repeatedly (Recurrent Self-Harm).  Effect sizes were 
calculated on the global SCL-90-R scores between these three groups, with an effect size 
of 0.46 for the No Self-Harm and Episodic Self-Harm groups, and an effect size of 1.07 
between those in the No Self-Harm and Recurrent Self-Harm group.  As the proposed 
study will not distinguish between those who self-harm episodically and those who self-
harm repeatedly, an average effect size of 0.76 was calculated on the basis of this 
previous research.  Setting the alpha level at 0.05 and power at 0.8, the calculation 
revealed a total sample of 46, with 23 participants in each group.  This sample size was 
also considered sufficient for the correlation analysis, assuming a medium to large effect 
size of 0.35. 
 
3.4.7 Settings and Equipment 
The research will take place on the acute receiving wards at each hospital site identified 
and will involve the completion of the measures specified. 
 
3.4.8 Data Analysis 
Data analysis will be undertaken using the Statistics Package for the Social Sciences for 
Windows (SPSS for Windows) software programme.  Descriptive statistics will be reported 
for demographic factors and analysis will be undertaken to confirm that both groups are 
appropriately matched.  
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The main comparison will be between the two group of participants on perceived stigma 
and SCL-90-R global scores.  If the data are normally distributed, statistical analysis will 
be undertaken using an independent samples t-test.  If the data are not of sufficient 
parametric quality, Mann-Whitney U tests will be performed.  Correlations will be carried 
out between perceived stigma scores and SCL-90-R global scores, and between 
perceived stigma scores and subscales of SCL-90-R.   
 
4.  Health and Safety Issues  
As this research will be undertaken on different hospital sites within NHS Greater Glasgow 
& Clyde, local Health and Safety policies will be adhered to.  In the event of any health 
and safety related incident, the appropriate health and safety procedures will be followed. 
 
4.1 Researcher Safety Issues 
Specific researcher safety issues have been carefully considered.  Ward staff will be 
consulted to identify appropriate potential participants to be approached about the study.  
These staff members will be informed when the principal researcher is meeting with 
potential participants and these meetings will occur on suitable premises on the wards.   
 
4.2 Participant Safety Issues 
As the study does not involve invasive procedures or deception of any kind, there are no 
obvious risks to participant’s integrity or well-being and no specific participant safety 
issues have been identified.   
 
5.  Ethical Issues  
Ethical approval will be sought from the NHS Greater Glasgow & Clyde Ethics Committee 
and the project will be registered with the Research and Design Directorate.  The British 
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Psychological Society’s guidelines on ethical issues in research (British Psychological 
Society, 2004) will be adhered to during this project. 
 
Given the possible vulnerable psychological state of individuals who have been admitted 
to general wards after an incident of self-harm, there are some ethical considerations 
about the potentially distressing aspect of undertaking this research.  As these patients 
will remain on a hospital ward while completing measures, follow-up care can be provided 
by healthcare staff present, as required.  Additionally, each participant in the self-harm 
group will be approached after a routine risk assessment appointment with the Glasgow 
Liaison Psychiatry Service, so any individuals who would be considered too vulnerable to 
participate will be excluded from the study.  As this risk assessment appointment allows 
the identification of relevant services and agencies to support each individual, follow-up 
care can be provided by these services as appropriate.  If participants in the control group 
disclose mental health problems or psychological distress, the principal researcher will 
signpost them to relevant sources of support, such as their GP.  Ward staff will also be 
informed with their permission.  
 
6.  Financial Issues 
There is a cost implication for the questionnaire packs in terms of photocopying and for 
purchase of the SCL-90-R measure.  There is a further cost for envelopes in which to 
return the questionnaires.  The estimated cost of the study is £33.49. 
 
7.  Timetable 
Sept – Nov 2009:   Application for approval with NHS Greater Glasgow & Clyde 
Ethical Committee, and Research and Design Directorate 
 Preparation of site and materials 
Dec 2009 – April 2010: Data collection 
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May 2010: Data analysis 
June – July 2010: Research write-up 
 
8.  Practical Applications 
This research aims to expand on current research on mental health stigma and negative 
staff attitudes towards those who self-harm.  If high levels of perceived stigma are 
identified as occurring in those who engage in self-injury in comparison to hospital 
controls, it may be appropriate for Liaison Psychiatry staff to undertake additional training 
with general hospital staff to facilitate their understanding of the purpose and function of 
self-harm, as recommended by NICE guidelines.  This may be of particular importance 
given the potentially negative impact of stigma on self-esteem, which could have a 
maintaining role in self-harming behaviour. 
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